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Abstract 
 
 The unfavourable use of metal-based catalysts in organic synthesis can be 
overcome by using small organic molecules; organocatalysts.  Herein we report the 
development and synthesis of a novel range of organocatalysts derived from amino 
acids incorporating imidazole, thiourea and phosphoramide moieties to confer the 
capability to act as bifunctional organocatalysts.  Our organocatalyst, a 
phosphoramide derived from valine, showed initial success in the catalytic allylation 
of aldimine with allyltrichlorosilane, producing 40% ee. 
 
N
H
HN
Cl3Si
DIPEA, CHCl3
Catalyst 20 mol%
Proline 2.5 eq
NH
O
HNP
Ph
O
Ph
Organocatalyst
HO HO
 
 
 Oxazoline catalysts derived from 2-pyridines have been shown to be effective 
activators of trichlorosilane for the reduction of ketones and ketimines.  The reaction 
however suffered from chloride promoted ring opening of the catalyst.  By replacing 
the oxygen of the oxazoline moiety with sulphur we were able to successfully avoid 
this problem.  Further expansion of the substrate scope was achieved, heterocyclic 
imines were reduced in good enantioselectivity, up to 89% ee.  
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Preface 
 
 Environmentally friendly, selective and high yielding processes are integral 
to the development and synthesis of new therapeutic reagents and novel 
compounds.  This, coupled with the significance of chirality in nature and, more 
importantly, the human body, makes the efficient, green, generation of 
enantiomerically enriched products a key goal in modern organic synthesis. 
 Generation of single enantiomers of chiral compounds can be achieved in a 
variety of ways: racemate resolution, chiral pool, chiral auxiliaries and asymmetric 
catalysis.  Racemate resolution is undesirable as the maximum yield is 50% and the 
unwanted enantiomer must be disposed of.  Molecules readily available from the 
chiral pool (amino acids, terpenes etc.) have limited variation in structure and so 
multi-step syntheses are required to reach the target molecule.  Chiral auxiliaries 
must be covalently bound to the substrate, this increases the number of steps in a 
synthesis and the auxiliary must also be recovered or disposed of.   
 Asymmetric catalysis is advantageous, as it uses achiral starting materials 
and requires only a catalytic amount of the chiral molecule, which offers the 
possibility of being recovered at the end of the synthesis.  Asymmetric catalysis is 
widely used in industry due to its advantages over other stoichiometric methods. 
 Most commonly in industry, transition metal complexes are used as 
asymmetric catalysts because of their high reactivity and high selectivity; for 
example ready-made mixtures of some catalytic systems are commercially 
available, eliminating the need to weigh several compounds.  Transition metal 
catalysis has become so important that in 2001 the Nobel Prize for chemistry was 
awarded to Knowles, Noyori and Sharpless for their contributions to asymmetric 
catalysis.  However, transition metal catalysis is not free from problems.  The 
metals used are often expensive, toxic and can be difficult to recover from the 
reaction products.  In pharmaceutical products this can prove problematic due to 
the toxicity, cost of the metal and its recovery. These issues can be resolved by 
employing organocatalysis.[1] 
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 In light of this, the field of organocatalysis has received considerable 
attention in recent years.[2,3]  Although organocatalysis has been known since the 
early part of the twentieth century at least[4,5], the past decade has seen a vast 
advancement in the field.  There has been large growth in the number of papers 
published in this area and the number of new organocatalytic systems being 
discovered.[2,6,7]  Organocatalysts are small organic molecules.  They offer a 
favourable alternative to metals as they are less toxic, cheaper and can often be 
used under an aerobic atmosphere with wet solvents.  Small organic molecules also 
offer the possibility of being recovered and reused, unlike many transition metal 
catalysts.   
 Organocatalysts can act by coordination to the substrate to render it more 
reactive.  This is often the case when amines are used as organocatalysts and is 
typified by enamine activation shown by proline.[8,9]  Organocatalysts can also act 
through weak non-covalent interactions: in this case the substrate or reagent is 
activated by coordination to the organocatalyst.  The activation of organosilicon 
reagents is one such example; this chapter will focus on the reactions of silicon 
reagents and the organocatalysts employed in these processes. 
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1 Introduction 
 
1.1 Lewis Basic Activation of Silicon 
 
 Addition of nucleophilic reagents to carbonyl compounds is an area with 
great importance in organic synthesis.  Reactive nucleophiles such as LiAlH4 and 
Grignard reagents efficiently add to carbonyl compounds, however less reactive 
nucleophiles such as allyltrichlorosilane and trichlorosilane do not react so readily 
and additional activation is required.  This can be achieved by either adding a Lewis 
acid to trialkylsilanes or a Lewis base in the case of trichlorosilanes (Scheme 1.1). 
 
O
HR
OH
R
MgBr
SiMe3
SiCl3
+ LA
+ LB
*
 
Scheme 1.1: Activation of silanes. 
 
 Activation can occur through either Lewis acid coordination to the carbonyl 
oxygen or through Lewis basic activation of the nucleophilic silane compound.  
Typically in organocatalysis activation of silanes by Lewis bases is the preferred 
method.[10] As organosilicon reagents are generally unreactive, only the 
coordinated silicon species will react.  If the activator employed can dissociate from 
the silicon intermediate at a sufficient rate, it can act as a catalyst rather than a 
stoichiometric reagent.  The use of a chiral Lewis basic catalyst would naturally 
allow for the preferential formation of a single enantiomer.  
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Figure 1.1: Expanding coordination of organosilicon reagents 
 
 Coordination of a Lewis base to an organosilicon reagent, 1, can expand the 
coordination sphere of silicon resulting in a pentacoordinate, 2, or hexacoordinate, 
3, species.[11,12]  This results in increased positive charge on silicon and increases the 
negative charge on the ligands (Figure 1.1).[13,14]  If the increased negative charge 
lies on a ligand which may act as a nucleophile then the hypervalent species can be 
considered as activated towards nucleophilic attack on an electrophile.  In the case 
of hexacoordinate silicon, 3, it is possible for a cationic species to be generated by 
ionisation of an electron-withdrawing ligand, such as a halide.  This results in a 
significant increase in Lewis acidity at silicon and can hence facilitate the activation 
of an electrophile, such as a carbonyl group, by coordinating to a non-bonding lone-
pair of oxygen.[15]  Organocatalytic protocols based on silane reagents have taken 
advantage of the tendency of Lewis bases to activate silane reagents as 
nucleophiles and enhance the Lewis acidic character of silicon.[16] 
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1.2 Allylation Reactions at C=O 
 
 The addition of allylsilanes to aldehydes is an important carbon-carbon bond 
forming reaction that has come under much recent scrutiny.[2,17,18]  Part of the 
reason for the interest in this reaction has been the ability to generate homoallylic 
alcohols with high enantio- and diastereoselectivity and the synthetic versatility of 
the end product.  Although the reaction is typically carried out by Lewis-acidic 
(metallic) activation of the carbonyl component or by employing reactive 
organometallic allyl reagents, the development of Lewis basic activation of 
allylsilanes has allowed the use of organic molecules as promoters 
(organocatalysts). 
 Lewis base promoted allylation of aldehydes with allylsilanes was pioneered 
by Kobayashi using dimethylformamide as a stoichiometric activator of 
allyltrichlorosilane, 4.[19,20]  Interestingly, when crotyltrichlorosilanes, 5, were used, 
the reaction proceeded stereospecifically suggesting the reaction operates via a 
closed cyclic transition state, 6 (Scheme 1.2).   Since this initial discovery, a range of 
further Lewis basic substances that facilitate the allylation reaction have been 
identified.  Typical Lewis basic activators include DMSO[19-22] and HMPA[22,23] as well 
as compounds with formamide[24,25] and urea[26] structural motifs. 
 
O
SiH
R2
R1
Cl O
Cl
Cl
N
H
Me Me
R2
R1 SiCl3
R
O
R H
OH
R
R2 R1
DMF
+
4: R1=H, R2=H
(trans)-5: R1=Me, R2=H
(cis)-5: R1=H, R2=Me
6
 
Scheme 1.2: Kobayashi closed TS 
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1.2.1 Phosphoramide Organocatalysed Allylations 
 
 The asymmetric Lewis base promoted allylation of aldehydes was pioneered 
by Denmark who showed that chiral phosphoramides were able to successfully 
produce enantioenriched homoallylic alcohols,[22] although the phosphoramide 
catalyst 7 exhibited only modest enantioselectivity.  It was shown that the addition 
of trans and cis 5 resulted in generation of the anti or syn products respectively, 9, 
with high diastereoselectivity (Scheme 1.3).  The transfer of stereochemistry from 
double bond to product in the crotylation reaction strongly suggests that the 
reaction proceeds via a closed cyclic transition state, much like that proposed by 
Kobayashi. 
 
H
O OH
R2R1
SiCl3
R2
R1
N
P
N
Me
Me
O
N
CH2Cl2, -78
 oC
+
4: R1=H, R2=H
(trans)-5: R1=Me, R2=H
(cis)-5: R1=H, R2=Me
7
silane cat loading (%) yield (%) anti/syn ee (%)
4
(trans)-5
(cis)-5
100
100
100
80
68
72
N.A.
98/2
2/98
60
64
60
6 8: R1=H, R2=H
(anti)-9: R1=Me, R2=H
(syn)-9: R1=H, R2=Me
 
Scheme 1.3: Phosphoramide catalysed allylation of benzaldehyde – Denmark 
 
 To further probe the reaction mechanism and dependence of selectivity on 
catalyst loading, a kinetic study was carried out by Denmark.[27]  A non-linear 
relationship between the enantiopurity of catalyst 7 and product 8 was found, 
suggesting that two molecules of catalyst are involved in the transition state.  It was 
also proposed that a second, less selective one-catalyst pathway may operate at 
low phosphoramide levels.  In order to reduce the effects of the second, less 
selective pathway, Denmark designed bisphosphoramide catalysts (Chart 1.1).[27,28]  
P a g e  | 7 
 
Variation of the length of carbon chain linking the phosphoramide units identified a 
five-methylene tether as the optimum, 10b.  Increased selectivity was observed 
with the use of organocatalysts 11a-c, derived from (R,R)-2,2’-bispyrrolidine.  Again, 
the optimum tether length was determined as five methylene units.  Bis-
phosphoramide 11b catalysed allylation of benzaldehyde 6 (loading of 5 mol%) 
furnishing the allylic alcohol in 85% yield and 87% ee.   Catalyst 11b was also 
successful in the allylation of a range of aromatic, heteroaromatic and unsaturated 
aldehydes.[28] 
 
N
P
N
Me
Me
O
N
P
N
Me
Me
O
n N
P
N O
N
P
NO
n
H
HH
H
10a: n=4
10b: n=5
10c: n=6
11a: n=4
11b: n=5
11c: n=6  
Chart 1.1: Bis-phosphoramide organocatalysts. 
 
 In order to further understand the reaction mechanism, Denmark carried 
out a number of studies involving bis-phosphoramide catalysts 10b and 11b.[29]  In 
these studies, complexes of phosphoramides with SnCl4 were synthesised and their 
properties were studied both in solution and in solid state.  Complexes with Sn 
exhibit similar bonding to those of Si but are also more stable making them easier 
to study.  The similarity in bonding between Si and Sn complexes allows results 
based on Sn to be extrapolated to the corresponding Si complexes.  Based on 
crystallographic data and 31P and 119Sn NMR studies, Denmark proposed that trans-
coordination of the silane to the Lewis basic organocatalyst enhances the 
nucleophilicity of the allyl group.  In addition, the aldehyde should preferably 
coordinate trans to the electron-withdrawing chloride group to enhance its anionic 
character.  Coordination of both Lewis basic catalyst and aldehyde to silicon in this 
fashion generates a chiral pocket, 12, in which enantioselective allylation can occur 
(Figure 1.2).   
 
P a g e  | 8 
 
 
Si
LB
Cl
LB
Cl
Cl
OR
R1
R2
12
 
Figure 1.2: Proposed method of allylation promoted by Lewis basic organocatalysts. 
 
1.2.2 N-Oxide Organocatalysed Allylations 
 
N N
O O
13 Nakajima
N N
Ph O O Ph
OHHO
14 Hayashi
N
O
RR
15 R = H; PINDOX
16 R = Me; Me2PINDOX
N N
O
17 iso-PINDOX
N
O O
O
O
18 METHOX
N
O O
19 QUINOX
 
Chart 1.2: N-oxide based organocatalysts for allylation reactions 
 
 Another successful class of organocatalysts for the Lewis-base promoted 
allylation with allyltrichlorosilanes are N-oxides (Chart 1.2).  The use of N-oxides 
was pioneered by Nakajima, who demonstrated that chiral N,N’-bisoxide 13 
allowed successful transformation in high yield and selectivity (71 – 92% ee) at -78 
oC with a catalyst loading of only 10 mol% (Table 1.1, entries 1-4).[30]  Similar to the 
phosphoramide catalysed allylation reactions, a six-membered transition state was 
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proposed due to the high diastereoselectivitiy observed upon the addition of trans 
and cis crotylsilanes (Figure 1.2). 
 Further to Nakajima’s work, a more active N,N’-bisoxide 14 was developed 
by Hayashi.[31]  High yields are observed with as little as 0.1 mol% catalyst loading; 
however enantioselectivity was highly dependent on the electronic nature of the 
substrate aldehyde (Table 1.1, entries 5, 6).  Electron-deficient aldehydes produced 
homoallylic alcohols with lower enantioselectivity than that of their electron-rich 
counterparts.  Hayashi suggested that the difference between electron-rich and 
electron-poor aldehydes could be attributed to π-stacking between the aldehyde 
and catalyst in the transition state. 
 
Ar H
O
Ar
OH
R2R1
SiCl3
R2
R1
+
4: R1=H, R2=H
(trans)-5: R1=Me, R2=H
(cis)-5: R1=H, R2=Me
silane catalyst yield (%) anti/syn ee (%)
4
(trans)-5
(cis)-5
Ar
4
Ph 13 85 NA
4-MeOC6H4 91
Ph
Ph 13
68 97/3
64 1/99
NA
4
4
Ph
4-MeOC6H4
14 95 NA 84 (S)
88 (R)
92 (R)
86 (R)
84 (R)
14 96 NA 94 (S)
13
13
*
entry
1
2
3
4
5
6
Table 1.1: Allylation with bis-N-oxides 13 and 14. 
 
 Malkov and Kocovsky reported the use of a series of catalysts derived from 
terpenes; bypyridine N-monoxides 15 – 17.[32,33]  N-oxide 15, PINDOX, emerged as 
an efficient catalyst for the allylation of aromatic and heteroaromatic aldehydes 
(Table 1.2, entries 1 - 5).  Further studies, however, revealed that Me2-PINDOX 16 
was much more efficient than its analogues PINDOX, 15, and iso-PINDOX, 17.  It was 
proposed that the restriction to axial rotation imposed by 3,3’-methyl groups 
created a favourable chiral environment upon coordination to silicon.  Asymmetric 
P a g e  | 10 
 
induction is controlled by the configuration of the 2,2’-bipyridyl bond as shown by 
using both the (+) and (-) atropisomers of Me2-PINDOX, 16.  Thus, when the (+) 
atropisomer (10 mol%) was used, the homoallylic alcohol (S)-8 was isolated in 72% 
yield and 98% ee (Table 1.2, entry 6); while (-)-16 results in the formation of the (R)-
8 in 82% ee and 67% yield (Table 1.2, entry 7).  To account for the observed results, 
a bidentate coordination of silicon through both O and N resulting in a 
hexacoordinate silicon species was proposed. 
 
entry catalyst Ar yield (%) ee (%)
1 Ph 78 90 (S)
2 4-MeOC6H4 68 87 (S)
3 4-NO2C6H4 58 65 (S)
4 52 83 (S)
5 2-furyl 63 85 (S)
6
15
15
15
15
15
(+)-16 Ph 72 98 (S)
7 (-)-16 Ph 67 82 (R)
8 17 Ph 15 97 (S)
9 17 4-MeOC6H4 41 91 (S)
10 17 25 96 (S)
PhCH=CH2
PhCH=CH2  
Table 1.2: Allylation of aldehydes with PINDOX and its derivatives. 
 
 It was discovered that METHOX, 18, lacking the second pyridine ring was 
much more active and achieved the same levels of enantioselectivity as PINDOX 
analogues, 15 - 17.[34,35]  In light of this Malkov and Kocovsky proposed that 
aromatic interactions between the catalyst and substrate may play a crucial role in 
determining the configuration of the transition state, rather than a second 
coordination point for Si.  In addition it was found that METHOX, 18, remained 
highly active even at low loadings (1 mol%) and is tolerant of aldehyde electronics 
(Table 1.3, entries 1-5). 
 While METHOX exhibited good selectivity regardless of aldehyde electronics, 
related N-oxide catalyst, 19, QUINOX displays high dependence on the electronics 
of the substrate aldehyde.[36]  Employing QUINOX, 19, it was found that the reaction 
of electron-poor aldehydes proceeded with higher rate and selectivity than the 
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equivalent electron-rich aldehydes (Table 1.3, entries 6–9).  More recent 
investigations involving computational and kinetic studies by Malkov and co-
workers have indicated that the reaction is likely to proceed via an associative 
reaction mechanism involving one molecule of organocatalyst that generates an 
octahedral silicon complex, 20 (Figure 1.3).[37]   
 
entrya catalyst Ar yield (%) ee (%)
1 18 Ph 95
2 18 Ph
loading (%)
5
1 68
3 18 4-CF3-C6H4 5 86
4 18 4-MeO-C6H4 5 95
5 18 2-MeO-C6H4 5 95
6 19 Ph 5 60
7 19 4-MeO-C6H4 5 70
8b 19 4-NO2-C6H4 5 73
9 19 4-CF3-C6H4 5 85
[a] All reactions carried out at -40 oC. [b] Reaction complete after 12h
87 (R)
12 (R)
89 (R)
96 (R)
solvent
CH2Cl2
CH2Cl2
CH2Cl2
CH2Cl2
MeCN
MeCN
MeCN
MeCN
MeCN
96 (S)
95 (S)
93 (S)
96 (S)
89 (S)
 
Table 1.3: Allylation of aldehydes with 18 and 19. 
 
 
O
Si
H
Ph
Cl Cl
O
Cl
N
MeO
20
 
Figure 1.3:  Proposed TS for allylation of aldehydes with QUINOX 19. 
 
 Crotylation of aldehydes catalysed by PINDOX and its derivatives, 15 - 17, 
resulted in the highly diastereoselective formation of homo-allylic alcohols 9.  The 
transfer of stereochemistry from double bond to alcohol was consistent with the 
presence of a closed cyclic transition state, i.e. the trans alkene produces the anti 
product and cis gives the syn products.  METHOX reacts well with trans-5, 
generating anti-9 with very high diastereoselectivity (>99:1) and high ee (95%).  The 
reaction with cis-5 however is slow and not as diastereoselective (6:1). 
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 Crotylation with QUINOX, 19, as the organocatalyst has been shown to 
exhibit high diastereoselective control.[36,37]  Reaction with trans and cis-5 formed 
the corresponding allylic alcohols with high diastereoselectivity, 95:5 and 1:99 
respectively (Table 1.4).  It was again observed that electron-rich aldehydes did not 
react as well as their electron-poor counterparts. The results indicate that 
crotylation with QUINOX, 19, proceeds via a closed chair-like transition state, 
similar to that proposed by Denmark (Figure 1.4).  Computational studies also 
suggested that aromatic interactions between catalyst and substrate may play a 
contributory role in the enantiodifferentiation process. 
 
 
R Silane Yield anti:syn
CF3 trans 75 96:4
H trans 65 95:5
CF3 cis 85 1:99
H cis 78 1:99
MeO trans 40 83:17
MeO cis 50 4:96
O
R
SiCl3
R2
R1
R
OH
R2R1CH2Cl2, -40 
oC
(trans)-5: R1=Me, R2=H
(cis)-5: R1=H, R2=Me
+
(S)-QUINOX
(anti)-9: R1=Me, R2=H
(syn)-9: R1=H, R2=Me
 
Table 1.4: Crotylation of aldehydes with QUINOX 
 
SiClnO
LB*
Closed TS
high diastereoselectivity  
Figure 1.4: Allylation transition state, LB* = chiral Lewis Base (organocatalyst) 
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 The application of tri-N-oxides as Lewis basic activators for this reaction has 
also been reported by Kwong.[38]  Terpene derived pyridine-N-oxides 21 – 22 were 
shown to be effective with loadings of 10 mol% (Chart 1.3, Table 1.5).  Enantiomeric 
excess of up to 86% ee was reported however the selectivity proved to be 
dependent on the electronics of the aldehyde; again; electron-poor aldehydes gave 
the highest selectivity. 
 
N
N NO
O O
N
N NO
O O
R R
21
22a R = n-Bu
22b R = Bn  
Chart 1.3: Terpene derived N-oxide organocatalysts 
 
O
R H
SiCl3
R
OH
Entry Catalyst R Yield (%) ee (%)
1 21 Ph 85 34 (R)
2 22a Ph 87 67 (R)
3 22b Ph 89 74 (R)
4 22b 4-MeO-C6H4 94 65 (S)
5 22b 4-CF3-C6H4 91 86 (R)
+
i-PrNEt2, CH2Cl2
O oC, 3 h
Catalyst 10 mol%
*
 
Table 1.5: Allylation catalysed by tri-N-oxides 21 – 22. 
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1.2.3 Formamide Organocatalysed Allylations 
 
 Chiral formamides have also been employed as organocatalysts for the 
allylation of aldehydes based upon the work of Kobayashi.[19]  Chiral DMF analogues 
were developed by Iseki and employed in the allylation reaction.[24,25]   Formamide 
23 was found to be an activator for the reaction however long reaction times at low 
temperature (7 days at -78 oC) were required to produce the allylic alcohol 24 in 
81% yield and 68% ee (Scheme 1.4).  It was found that the addition of 1.0 
equivalents of HMPA was beneficial to the reaction.  The product was formed in 
80% yield and 98% ee under optimum conditions, 1.0 eq HMPA as an additive, -78 
oC, 14 days.  Although 23 operates as a highly selective catalyst, the reaction rate is 
too sluggish to be considered synthetically useful.  It is worth noting, however, that 
23 exhibits high selectivity for aliphatic aldehydes (≥ 98% ee) but not with aromatic 
aldehydes. 
 
Me
N
Me
O H
23
O
H SiCl3
OH
+
CH2Cl2, HMPA
-78 oC, 14 days
(S,S)-23
(R)-24 80%, 98% ee
 
Scheme 1.4: Allylation reaction promoted by (S,S)-23. 
 
 More recently, Kobayashi described the use of a polymer supported 
formamide, 25, which can act as a recyclable promoter for the allylation of 
aldehydes with silanes (Scheme 1.5).[39]  Allylic alcohol 26 was formed in 91% yield 
using one equivalent of polymer supported catalyst 25.  It was also found that 25 
maintained its activity through several uses. 
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O
H SiCl3
OH
+
N
Me
H
O
25
Scheme 1.5: Allylation catalysed by polymer supported formamide. 
 
1.2.4 Pyridine-oxazoline Organocatalysed Allylations 
 
 The use of pyridine-oxazoline derivatives as activators for crotylation of 
aromatic aldehydes was reported by Barrett.[40]  Organic activator 27 derived from 
leucinol showed the best results for this transformation, giving excellent 
diastereoselectivity, >99% and moderate-to-good enantioselectivity, 36 – 74% ee 
(Scheme 1.6).  Formation of the anti-allylic alcohol only, indicates the involvement 
of a hyper-valent silicon species in a closed transition state. 
 
O
R H
SiCl3 R
OH
Me
+
27 110 mol%
CH2Cl2
-78 oC, 4 h
N
N
O
27
Entry R Yield (%) ee (%)
1 Ph 72 74
2 4-MeO-C6H4 79 46
3 4-F-C6H4 61 74
4 4-O2N-C6H4 66 36
 
Scheme 1.6: Crotylation of aldehydes catalysed by pyridine-oxazolines. 
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1.3 Reduction of Ketones With Silanes 
 
 Silanes are widely accepted as efficient reagents for the reduction of 
carbonyl functionality.  In the case of alkyl silanes, transition metal catalysts are 
required to activate the reagent[41]; in the case of more Lewis acidic trichloro- and 
trialkoxysilanes, a metal-free variation can be attained by employing an organic 
activator (Scheme 1.7). 
    
O
R2R1
X3SiH+
OH
R2R1
Activator
*  
Scheme 1.7: Reduction of ketones with silanes 
 
1.3.1 Anion Promoted Reduction 
 
 Trialkoxysilanes were reported as reducing agents for carbonyl compounds 
by Corriu.[42,43]  Although generally unreactive towards carbonyl functionality, 
triethoxysilane turned into a reactive hypervalent silicon species upon coordination 
of fluoride anions.  A range of carbonyl compounds were reduced by silanes 
catalysed by alkali metal fluorides. 
 More recently, Lawrence has reported the use of chiral quinidine fluoride 
salts as phase-transfer catalysts for an asymmetric variant of this reaction.[44]  
Activation of trimethoxysilane is again achieved by forming a hypervalent silicon 
species with fluoride anions.  The use of chiral cinchona derived catalyst 28 led to 
the formation of sec-alcohols in up to 78% ee (Scheme 1.8).  It was also found that 
aromatic sec-alcohols were formed with higher levels of enantiodiscrimination than 
their aliphatic counterparts. 
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N
Ph
N
OMe
HHO
O OH
29 (S)-30, 99%, 78% ee
28 10 mol%
(Me3SiO)3SiH
THF
28
 
Scheme 1.8: Reduction of ketones with cinchona derivative 28 
 
 Alkoxides also turned into effective activators of silicon for the reduction of 
ketones to alcohols with silanes as shown by Hosomi (Chart 1.4).[45]  Lithium 
alkoxide 31 generated a hypervalent silicon species which converted a range of 
ketones to the corresponding alcohols in good yield.  Hosomi then developed chiral 
alkoxides as activators of silicon, resulting in an asymmetric transformation.[46]  
Alkoxide 32 successfully reduced acetophenone, 29, in 78% yield and 44% ee with a 
loading of 40 mol%.   
 Additionally, lithium salts of L-Histidine and BINOL have been developed as 
activators of trialkoxysilanes by Brook[47,48] and Kagan[49] respectively.  The lithium 
salt of L-Histidine, 33, formed (S)-phenylethanol, 30, in 70% yield and only 26% ee; 
the monolithium salt of BINOL, 34, formed (S)-phenylethanol, 30, in 92% yield and 
70% ee;  34 was also shown to be highly effective for a range of ketones forming 
the sec-alcohol products in good selectivity (up to 93% ee).  In both cases the 
addition of TMEDA was found to be beneficial to the activity of the catalytic system, 
presumably as it prevents the organolithio compounds from aggregating. 
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LiO
LiO
LiO
LiO
OBn
OBn
LiO O
NH2
N
N
Li
OH
OH
31 32 33 34  
Chart 1.4: Lithium alkoxide activators 
 
1.3.2 Formamide Promoted Reduction 
 
 Kobayashi described the reduction of ketones to sec-alcohols with the use of 
a dimethylformamide-trichlorosilane complex.[50]  The hypervalent silicon complex 
thus generated was shown to be an effective reducing agent for ketones, aldehydes 
and imines.  Trichlorosilane proved to be a more desirable reducing agent than 
trialkoxysilanes as it is less toxic, cheap and easy to handle.  Perhaps unsurprisingly, 
this led to the development of chiral formamide derivatives as activators of 
trichlorosilane for the reduction of the carbonyl functionality. 
 
N
OH
N
OH
N
OH
H
N Ph
H
N
O O
NHO2C
Et
Et
EtO
35 36 37 38
Chart 1.5: Formamide activators of Cl3SiH 
 
 Matsumura showed that N-formylpyrrolidine derivatives were able to 
effectively activate trichlorosilane towards reduction in only catalytic quantities 
(Chart 1.5).[51]  The initial non-enantioselective reduction was carried out with 10 
mol% of formamide 35, resulting in formation of phenylethanol in 92% yield.  By 
employing chiral formamide 36 derived from proline some enantiodiscrimination 
was observed.  Enantioselectivity was increased when formamide 37 was 
employed, giving the product in 43% ee.  Matsumura proposed steric repulsion 
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between the aryl groups of the catalyst and ketone as a rationale for 
enantioinduction (Figure 1.5). 
 
N
O
H
HN
O
Si
H
ClCl
O
Me
Cl N
O
H
HN
O
Si
H
ClCl
O
Cl
favoured disfavoured  
Figure 1.5: Matsumura’s proposed transition state. 
 
 More recently, Matsumura reported the related formamide 38 (Chart 1.5) 
as an efficient activator of silanes towards reduction of ketones.[52]  Formamide 38 
reduced aromatic ketones containing both electron-donating and electron-
withdrawing substituents in high selectivity, up to 97% ee (Table 1.6).  Acetyl 
ferrocene was also successfully reduced by 38 at -60 oC in 97% yield and 99.7% ee.  
It was found that the carboxyl group and 2,4,6-triethylphenyl group at the α and α’ 
positions were required for high selectivity and reactivity.  This may suggest 
hydrogen bonding interactions between the catalyst and either ketone or silane.  
Aromatic interactions between catalyst and substrate may also be suggested as a 
rationale for selectivity.   
 
Entry R Yield (%) ee (%)
1 Ph 90 95 (R)
2 4-NO2-C6H4 93 97 (R)
3 93 97 (R)
4 91 94 (R)
O
R Me
OH
R MeHSiCl3, CHCl3
rt
38 10 mol%
4-Cl-C6H4
4-F-C6H4
 
Table 1.6: Reduction of ketones with formamide 38. 
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 Pipecolinic derived formamides, 39 – 43 (Chart 1.6), were found to be 
effective for the reduction of ketones with trichlorosilane by Sun and co-workers.[53]  
Formamide derivative 43 was found to be the most efficient promoter of the 
reduction reaction; aromatic ketones were reduced in high yield and 
enantioselectivity (Table 1.7, entries 1 – 3).  Interestingly, aliphatic ketones were 
effortlessly reduced in moderate to high selectivity (Table 1.7, entries 4 and 5).   
 
N
OH
H
N Ph
PhO
Ac
O
N
OH
H
N Ph
PhO
R
O
39 40 R = Ac
41 R = CHO
42 R = Et
43 R = Me  
Chart 1.6: Pipecolinic derived formamide organocatalysts. 
 
 
Entry R Yield (%) ee (%)
1 4-CF3-C6H4 92 92 (R)
2 4-NO2-C6H4 92 91 (R)
3 Ph 94 81 (R)
4 c-C6H11 90 88 (R)
5 i-Pr 81 53 (R)
O
R Me
OH
R MeHSiCl3, toluene
-20 oC
43 10 mol%
 
Table 1.7: Reduction of ketones with formamide 43. 
 
 The methoxy substituent at the 2’ position was found to be crucial to 
enantiodifferentiation as replacement of this group results in lower selectivity.  
Furthermore it was found that reversal of the stereochemistry at C-2’ or removal of 
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the alkoxy group had a detrimental effect on both selectivity and reactivity.  Based 
on their observed results, Sun et al proposed a transition state based on 
tricoordinate activation of silane by the organocatalyst to generate a 
heptacoordinate silicon species, 44, as the active reducing agent (Figure 1.6). 
 
Si
Cl
O
Cl H
O ClH
N
H
N
O Me
Ph
Ph
OR
44
 
Figure 1.6: Sun proposed transition state for reduction of ketones. 
 
1.3.3 Oxazoline Promoted Reduction 
 
 
N
N
O
N
N
O
N
N
O
Ph Ph
Ph
45 46 47  
Chart 1.7: Pyridine oxazoline activators of silanes 
 
 More recently Malkov and Kocovsky described the use of pyridine 
oxazolines as highly effective organocatalysts for the reduction of ketones with 
trichlorosilane (Chart 1.7).[54]  When phenylglycine derived pyridine oxazoline 45 
was effectively employed for the hydrosilylation of acetophenone, 29, the resulting 
alcohol, 30, was obtained in low yield and moderate enantioselectivity (Table 1.8, 
entry 1).  In contrast, the isomeric pyridine oxazoline 46, obtained from mandelic 
acid, reduced acetophenone, 29, in 85% yield and 78% ee (Table 1.8, entry 2).  
Steric interactions between the chiral aryl group and the silane ligands, resulting in 
poor coordination of the silane to 45, were proposed to account for the difference 
in selectivity between 45 and 46.  A range of ketones were examined in the 
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reduction reaction catalysed by 46, high enantioselectivity was observed only in 
aromatic ketones (>80% ee), while aliphatic ketones performed rather poorly.   
 In order to increase activity and selectivity, catalyst 47 derived from 1-
isoquinoline and mandelic acid was developed.  Catalyst 47 was shown to be much 
more active over a range of substrates and allowed the catalyst loading to be 
dropped to 10 mol%.  Aromatic ketones were reduced in good yield with high 
enantioselectivity, >94% (Table 1.8, entries 3 – 7).  Malkov and Kocovsky proposed 
a transition state accounting for the high selectivity in which the oxazoline catalyst 
coordinates to trichlorosilane to form a hypervalent silicon species.  The ketone, 
coordinated to a second molecule of trichlorosilane, then approaches from the less 
hindered face; it was also suggested that aromatic interactions between ketone and 
catalyst may play a role in stabilising the transition state, 48 (Figure 1.7). 
 
O
R2R1 CHCl3, -20 
oC, 24 h
Organocatalyst
+ Cl3SiH
OH
R2R1
Entry Catalyst (mol%) R1, R2 Yield (%) ee (%)
1
2
3
4
5
6
7
45 (20)
46 (20)
47 (10)
47 (10)
47 (10)
47 (10)
47 (10)
Ph, Me
Ph, Me
Ph, Me
2-naphth, Me
Ph, Et
2-F-C6H4, Me
2-MeO-C6H4
29 66
85 78
85 84
55 86
50 87
35 70
93 94
 
Table 1.8: Organocatalytic reduction of ketones with oxazoline derivatives 
 
N N
O
Ph
HSi
Cl
Cl Cl
H
Me
O SiHCl3
*
48
 
Figure 1.7: Proposed transition state for catalyst 46. 
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1.4 Reduction of Imines with Silanes 
 
1.4.1 Anion Promoted Reduction 
 
 As an outcome to the activation of trialkoxysilanes for the hydrosilylation of 
ketones, Hosomi reported the use of lithium methoxide as a catalyst for the 
reduction of N-tosyl imines with trimethoxysilane.[55]   
 Attempts to render the reaction enantioselective by using lithium salts of 
various amino alcohols were unsuccessful however.[56]  An improvement in 
selectivity was observed using the dilithium salt of BINOL, 34.  The reduction of 49 
to 50 was carried out successfully in 65% enantioselectivity. 
 
N
MePh
(MeO)3SiH
Catalyst
HN
MePh
Catalyst = LiOMe: 63%
Catalyst = BINOL-Li2: 65% ee
*
49 50
Ts Ts
 
Scheme 1.9: Reduction of N-tosyl imines 
 
1.4.2 Formamide Promoted Reduction 
 
 Analogous to the reduction of ketones, Kobayashi described the generation 
of a hypervalent dimethylformamide-trichlorosilane complex and its effectiveness 
as a mild reducing agent for ketimines (Scheme 1.10).[50] 
 
N HN
*
DMF, HSiCl3
51 52  
Scheme 1.10: Reduction of ketimines with DMF-trichlorosilane. 
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 In a similar manner, Matsumura investigated the potential of pyrrolidine 
derived formamides as catalytic Lewis basic activators for the reduction of prochiral 
ketimines with trichlorosilane.[57]  Formamide 35 was shown to be much more 
effective than DMF for the achiral reaction, generating amine 52 in 79% yield.  By 
employing enantiomerically pure formamides 36 and 37, a small range of ketimines 
were reduced to the corresponding chiral amines in moderate enantioselectivity 
(Table 1.9).   
 
Entry Catalyst
N
MeAr
R
NH
MeAr
R
HSiCl3
Catalyst
Ar R Yield (%) ee (%)
1
2
3
35
36
37
Ph Ph 79 NA
Ph Ph 91 55 (R)
Ph Ph 52 66 (R)
 
Table 1.9: Reduction of ketimines with pyrrolidine derived formamides. 
 
 In a modification of the chiral scaffold developed by Matsumura, Malkov 
and Kocovsky reported valine derived formamides as highly selective 
organocatalysts for the reduction of ketimines with trichlorosilane (Chart 1.8).[58]  
Replacing the rigid cyclic core of the pyrrolidine formamides with a more flexible 
skeleton resulted in much higher levels of enantiodiscrimination; presumably as the 
more flexible system allows the catalyst to adopt a more favourable geometry in 
the transition state.  Although both 37 and valine derived formamide 54 have the 
same absolute configuration, the latter results in formation of the opposite 
enantiomer.   
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N
O
HN
O
H
R
N
O
HN
O
H
R
R
N
OH
N
OH
N
OH
H
N Ph
H
N
O O
NHO2C
Et
Et
EtO
35 36 37 38
53 R = H
54 R = Me
55 R = C6H11
56 R = t-Bu
57 R = CH3
58 R = CH2Ph
59 R = Ph
Chart 1.8: Formamide containing organocatalysts for reduction of ketimines 
  
 A range of prochiral ketimines were reduced with 53 and 54 as a catalyst 
(Table 1.10, entries 1 - 5); tuning the steric properties of the aromatic ring of the 
catalyst, as in 54, improved the reactivity.  It was found that selectivity was only 
observed with N-aryl imines.  In addition, non-polar solvents proved to be superior 
in terms of reactivity and enantioselectivity, with chloroform and toluene as the 
optimum.  Variation of the amino acid side-chain showed that bulkier groups such 
as cyclohexyl and t-butyl groups, 55 and 56, exhibited marginally reduced selectivity 
(Table 1.10, entries 6 and 7), while catalysts derived from alanine, phenylalanine 
and phenylglycine, 57, 58 and 59, were considerably less selective (Table 1.10, 
entries 8 – 10).   
 It was proposed that activation of trichlorosilane occurs through 
coordination to the formamide moiety in 54, it was also conjectured that the amide 
oxygen may play a role in coordinating silicon.  Arene-arene interactions between 
the catalyst and the N-aryl moiety of the imine were suggested as contributing to 
the enantiodifferentiating process.  The chirality of the amino acid side-chain is 
thought to be transmitted through the N-Me moiety of the catalyst. 
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Entry Catalyst Ar R Solvent Yield (%)
1
ee (%)
53 Ph Ph CHCl3 49 92 (S)
2a 54 Ph Ph CHCl3 94 92 (S)
3 54 Ph Ph Toluene 81 92 (S)
4 54 Ph PMP Toluene 85 91 (S)
5 54 Ph Bn Toluene 48 8
6 55
7 56
8 57
58
59
9
10
Ph PMP Toluene 95 82 (R)
Ph PMP Toluene 95 83 (S)
4-CF3C6H4 Ph Toluene 92 38 (R)
Ph PMP Toluene 84 49 (S)
Ph PMP Toluene 76 0
a Reaction carried out at -20 oC
N
Ar
R
HN
Ar
R
*
Catalyst 10 mol%
HSiCl3, 16h, rt
 
Table 1.10: Reduction of ketimines with amino acid derived formamides. 
 
 A range of formamide derived organocatalysts were developed by Sun, 60 – 
63, and shown to be effective for the reduction of ketimines with trichlorosilane 
(Chart 1.9).[53,59-61]  The most successful was shown to be 63, a formamide 
derivative of L-pipecolinic acid.  Similar to the reactivity of ketones (Table 1.7), 
formamide 63 effectively reduced not only aromatic ketimines, but aliphatic 
ketimines as well, in high yield and selectivity (Table 1.11).  Sun suggested that the 
reaction could not proceed through the analogous transition state as for ketone 
reduction (Figure 1.6) due to steric repulsion between the N-aryl moiety and 
catalyst methoxy group.  Instead it was suggested that the reduction of ketimines 
proceeds via a hexacoordinate silicon species (Figure 1.8).   
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N
H
S
O OH
F
N
N
OH
H
N
Ph
O
N
OH
H
N
O
N
OH
H
N
O
SO2(p-
tBuPh)
Ph
O Ph
Ac
Ph
O Ph
Me
60 61 62 63
Chart 1.9: Organocatalysts developed by Sun. 
 
 
Si
Cl
O
Cl H
O ClH
N
H
N
NR
Ph
Ph
O
Me
Ar
 
Figure 1.8: Proposed transition state for reduction of ketimines with 63. 
 
 
N
R
Ar
HN
R
Ar
Entry R Ar Yield (%) ee (%)
1 Ph Ph 94
2 Ph PMP 93 89 (R)
3 4-MeO-C6H4 Ph 96
4 4-CF3-C6H4 Ph 98
5 c-C6H11 Ph 93
6 i-Pr Ph 93
93 (R)
93 (R)
88 (R)
92 (R)
89 (R)
Toluene, -20 oC
HSiCl3
Catalyst 63
10 mol %
 
Table 1.11: Reduction of ketimines with formamide 63. 
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1.4.3 Oxazoline Promoted Reduction 
 
 In conjunction with their studies of pyridine-oxazoline promoted reduction 
of ketones, Malkov and Kocovsky described the reduction of ketimines with catalyst 
47.[54]  A small range of aromatic ketimines were converted to their corresponding 
amines in high enantioselectivity (≤87%, Table 1.12).  A similar mechanism to the 
reduction of ketones was proposed, with the N-aryl moiety replacing Cl3SiH 
coordinated to oxygen in the transition state (Figure 1.9).   
 
 
Entry
N
MeAr
HN
MeAr
HSiCl3
Catalyst
Ar R Yield (%) ee (%)
1
2
3
Ph Ph 65 87
Ph PMP 60 85
67 86PMP2-naphth
*
R R
 
Table 1.12: Reduction of ketimines with pyridine-oxazoline 47. 
 
 
N N
O
Ph
HSi
Cl
Cl Cl
H
Me
N
*
Ar
 
Figure 1.9: Proposed transition state for reduction of ketimines with 47. 
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1.5 Conclusions 
 
 The past decade has seen considerable advancement in the field of 
organocatalysis.  A vast number of small organic molecules have been reported as 
catalytic activators of asymmetric organic reactions.  A number of these 
organocatalysts may offer a viable alternative to traditional metal based catalysis 
due to the reported high yields and high enantioselectivity.   Although some 
organocatalysts may have some foreseeable industrial or commercial applications 
the field still suffers from several drawbacks. 
 Many organocatalysts are reaction specific and subtle changes in the 
catalytic structure can often render the organocatalyst completely inactive.  
Although general structural motifs can be identified and used as building blocks for 
new organocatalysts there are few examples of general organocatalysts.  Only 
proline seems to have any great ability to be active for a number of different 
reactions, however even proline is limited to reactions involving an enamine as the 
reactive species. 
 Substrate specificity is another drawback of contemporary organocatalytic 
reactions.  With the exception of formamides 23 and 43; the organocatalysts 
reviewed within are dependant on aromatic substrates to obtain good selectivity.  
In addition high catalytic loadings are often required compared to those used by 
metal catalysts. 
 These drawbacks can be capitalised on to improve the field of 
organocatalysis.  By endeavouring to develop more active organocatalysts it may be 
possible to lower catalyst loadings, improve substrate tolerance and increase 
crossover between different reactions.  In this way it should be possible to make 
organocatalysis a practicable alternative to metal based catalysis. 
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2 Bifunctional Organocatalysts  
2.1 Introduction 
 
 Organocatalysts can act by coordination/activation of substrate or reagent 
as discussed above.  However another class of organocatalysts exists, which may 
activate both reagent and substrate at the same time.  These bifunctional 
organocatalysts allow the substrate and the reagent to be brought close together 
and held in a specific geometry, mimicking the closed transition states of 
intramolecular reactions.  In this way, the use of bifunctional organocatalysts often 
exhibits a greater stereocontrol and an improved reactivity compared to 
monodentate organocatalysts. 
 The simple amino acid proline has emerged in recent years as one of the 
most effective organocatalysts for a wide number of bond forming reactions, in 
particular at the position α to the carbonyl group in aldehydes and ketones.[9,18,62]  It 
is now widely accepted that proline acts as a bifunctional organocatalyst involving 
both amine and carboxyl groups in the reaction pathway.[63]  The amine group is 
involved in generation of a nucleophilic enamine intermediate after undergoing 
condensation with the carbonyl group of the substrate.  The electrophile is then 
activated towards the nucleophilic attack by the enamine by H-bonding to the 
carboxylic acid group (Scheme 2.1).  In this way, dual activation of both the 
nucleophile and electrophile by the same molecule has led to the impressive 
generality of proline catalysis. 
P a g e  | 31 
 
N
H
CO2H
O
R'
R
N CO2H
R'
R
Y
X H
N
Z
R
R'
OO
Y
X H
N
Z
R
R'
OO
X
Y
Z
O
R'
Y
Z
XH
R
H2O
H2O
electrophile
 
Scheme 2.1: Proposed mechanism for proline-catalysed conversions 
 
 A similar strategy has also been used in the stereoselective silylation of diols 
by exploiting the ability of silicon to form hypervalent species.[12,64]  Hoyveda and 
Snapper et al. developed a simple amino acid based bifunctional catalyst for 
selective silylation of diols.[65,66]  Lewis basic sites incorporated in the catalyst 
structure, a secondary amine and amide oxygen, allow the substrate diol to 
coordinate to the catalyst backbone.  Generation of the activated hypervalent 
silicon species is mediated by the N-methylimidazole group integrated into the 
catalyst framework (Figure 2.1).  This facilitates quasi-intramolecular transfer of the 
electrophilic silicon moiety to the hydroxyl group.[66] 
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Figure 2.1: Proposed mechanism of catalyst activation of silanes and diols. 
 
 Inspired by this we sought to develop a range of novel bifunctional 
organocatalysts. 
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2.2 Target Compounds 
 
 Amino acids are among the simplest chiral frameworks and as such were 
chosen as the foundation for the new organocatalysts.  The naturally occurring α-
amino acids are widely available and are relatively cheap.  In addition both 
enantiomers are easily obtainable and many unnatural analogues are also available.   
Amino acids lend themselves to synthesis of bifunctional catalysts as they bear both 
an amino group and a carboxyl group making them easy to derivatise.  The chiral 
core would accommodate a formamide group for coordination of silane reagents.  
Substrate coordination would be achieved by incorporation of a group capable of 
hydrogen bonding to oxygen or nitrogen; in our case a thiourea or amide moiety.  
As we intend to carry out reactions on aromatic ketones or imines, an aromatic 
group would also be present to aid organisation of the organocatalyst and substrate 
through possible π-π interactions (Scheme 2.2).  
 
N
R1
R2 HN
HN
S
R3O
X
Ar
R4
Cl3Si
Y
NH
N
H
O
O
Ar
Cl3Si
Y
X
Ar
R4
R1 = Me, iPr, Ph; R2 = H, Me;
R3 = Aromatic; R4 = H, Me;
X = O, NAr; Y = H, allyl, crotyl etc.
N
N
 
Scheme 2.2: Planned mechanism of action for bifunctional organocatalysts. 
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2.3 Synthesis 
 
 The initial targets were identified as compounds 64 to 66 (Chart 2.1).  The N-
α-methyl group on target 64 is required to transmit the chirality of the amino acid 
scaffold closer to the reaction centre.[67]  In target 65 this methyl group is not 
required as the formamide moiety is not adjacent to the chiral group.  Imidazole is a 
known activator of silanes[11] and as such, histidine based catalyst 66 offers an 
additional coordination point for a silicon reagent.  Methylation of the imidazole 
ring proved to be necessary as previous tests demonstrated that N-α-Boc-histidine 
formed an insoluble complex with trichlorosilane.   
 
N
H
N
H
N
S
O
NH
O
O
N
H
N
N
N
H
H
N O
N
H
S π
τ
64 65 66
Chart 2.1: Target organocatalysts. 
 
It is known that direct ring alkylation of histidine usually results in a mixture 
of τ(N-1) and π(N-3) alkylated products.[68]  Generally alkylation at the τ(N-1) 
position is carried out by first protecting the π(N-3) position, as exemplified by 
Beyerman.[69]  A recent report, however, showed that at low temperature N-α-Boc-
histidine underwent selective deprotonation at the τ-(N-1) position using NaH in 
DMF,[70] which upon reaction with alkyl halides produced exclusively τ-alkylated 
products.  Following this protocol, N-α-Boc-N-τ-methyl-histidine was obtained by 
deprotonation of N-α-Boc-histidine, 67, with NaH in acetonitrile at -15 oC followed 
by reaction with methyl iodide.  The desired N-α-Boc-N-τ-methyl-histidine, 68, was 
isolated as pale yellow crystals in 66% yield (Scheme 2.3).  
Various coupling methods were tried to convert 68 to amide 69.  Coupling 
using the mixed anhydride method was unsuccessful.  Coupling using DCC under 
standard conditions resulted in formation of the desired amide, 69; however 69 
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was found to be inseparable from the reaction by-product, DCU. To facilitate 
separation of the product from the coupling by-products, it was decided to switch 
to related carbodiimide EDC.HCL.  The resulting urea is water soluble and therefore 
ought to be easily separated from the amide product by extraction.  Carrying out 
the coupling step using EDC.HCL, HOBT and NMM resulted in formation of the 
desired amide, 69.  Purification was easily accomplished by aqueous extraction of 
the reaction by-products followed by column chromatography to furnish 69 in 65% 
yield. 
Further investigation showed that EDAC.HCl could be utilized without 
employing other reagents, such as HOBT and NMM, thus simplifying the reaction 
procedure.  The N-Boc group was then removed with TFA in CH2Cl2 and converted 
to the formamide, 66, using a mixture of acetic anhydride and formic acid.  The 
target catalyst, 66, was obtained in 59% yield. 
 
HN
N
N
N
H
O
O
1. DCM/TFA 1:1, 1h
2. Ac2O, Formic Acid
   72h
H2N
HN
Boc
N
N
N
H
O
HN
CO2H
Boc
N
NHN
CO2H
Boc
HN
N
NaH, MeI
CH3CN, -15 to -5
oC
EDAC.HCl
MeCN
66
67 68
69
66%
65%59%
 
Scheme 2.3: Synthesis of N-α-formyl histidine derivative. 
 
 Synthesis of thiourea derived catalyst 75 began with reduction of Boc-valine 
to afford 71, followed by N-Boc protection to generate N-Methyl-N-Boc valinol, 72, 
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in good yield (87%).  Conversion of the alcohol to an amine was achieved by 
introduction of a phthalimide group via the Mitsunobu reaction.  This was then 
easily removed with hydrazine hydrate in ethanol to give the required amine, 73, in 
99% yield over two steps.  Treatment of the free amine 73, with 
phenyisothiocyanate afforded thiourea 74 in good yield, 88%.  Deprotection of the 
amine was achieved under standard TFA conditions.  Formylation with acetic 
anhydride and formic acid unexpectedly yielded either trifluoroacetamide 75, or 
acetamide 76 (Scheme 2.4).  Since the deprotected amine was isolated as the TFA 
salt it was thought that this was interfering in the formylation reaction.  Washing 
the crude deprotection mixture with a basic solution would remove any TFA and 
allow formation of the formamide, however when this was attempted only the 
amine 77 was isolated after 24h (Scheme 2.5).  Attempts to generate the desired 
compound by treatment with acetic formic anhydride were also unsuccessful. 
 
HN
O
OH
Boc
HN OH N OH
Boc
N NH2
Boc
N HN
Boc HN
S
Ph
N HN
HN
S
Ph
O
CF3
1. DCM:TFA
2. Ac2O
HCOOH
PhNCS, DCM
1. Phth, DEAD
PPh3, THF
2. N2H4, EtOH
Boc2O, DCMLiAlH4, THF
70 71, 87%
72, 87%
73, 99%74, 88%
75
N HN
HN
S
Ph
O
Me
76
or
 
Scheme 2.4: Synthesis of valine-thiourea derivative. 
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Scheme 2.5: Attempted formylation of 74. 
 It was thought that formylation of N-methyl valinol instead of Boc 
protection would circumvent the problems with formylation later in the synthesis 
(Scheme 2.6).  Formylation of N-methyl valinol, 71, by refluxing overnight in ethyl 
formate afforded the desired product, 78, in excellent yield (99%).  The phthalimide 
group was then introduced using the Mitsunobu protocol however it was 
discovered that 79 was inseparable from the reaction by-products.  It was found 
that to successfully synthesise and isolate the target catalyst 64; the 
deprotection/formylation step had to occur between the Mitsunobu and 
phthalimide removal steps.  N-Me-N-Boc valinol was converted to phthalimide 
derivative 80 under Mitsunobu conditions.  Deprotection of the Boc group and 
formylation was carried out under standard conditions to afford 81.  Removal of the 
phthalimide group to reveal the amine 82 was effected with hydrazine in ethanol.  
Treatment of N-Me-N-formyl valamine 82 with phenylisothiocyanate yielded the 
desired compound 64 in 56% yield (Scheme 2.7). 
 
NH OH N OH N
O O
N
O
O
Ethyl formate
reflux
Phth, PPh3
DEAD, THF
71 78, 99% 79  
Scheme 2.6: Alternative formylation protocol. 
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Scheme 2.7: Synthesis of thiourea derivative 64. 
 
 The synthesis of thiourea derivative 65 commenced with reduction of L-
valine, 83, with LiAlH4 (Scheme 2.7), which afforded L-valinol, 84, in 66% yield.  
Protection of the amine was carried out with di-tert-butyl dicarbonate in the 
presence of triethylamine, to afford the protected amino alcohol, 85, in 84% yield, 
which was then converted to the phthalimide derivative, 86, by Mitsunobu reaction 
in 48% yield.  Phthalimide deprotection by hydrazine hydrate in ethanol yielded the 
mono protected diamine 87.  The formamide derivative, 88, was obtained by 
refluxing the mono protected diamine in ethyl formate.  The Boc group was then 
removed with a TFA/DCM mixture (1:2) and the amino formamide treated with 
phenylisothiocyanate to afford catalyst 65 in 12% yield from 88. 
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Scheme 2.8: Synthesis of thiourea derivative 65. 
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2.4 Application in Model Catalytic Reactions 
  
 Allylation of aldehydes and reduction of ketones and imines are reactions 
that can be carried out using silane reagents.[18]  The synthetic versatility of the 
chiral end-products of these reactions has prompted investigation into an 
organocatalytic protocol.  With this in mind it was proposed that the prospective 
catalysts would be tested in the reduction of ketones and ketimines with 
trichlorosilane, and allylation of aldehydes with allyltrichlorosilane respectively 
(Scheme 2.9). 
 
H
O OH
X XH
Cl3Si
HSiCl3
Catalyst
Catalyst
30 X = O
89 X = NAr
*
*
 
Scheme 2.9: Model catalytic reactions. 
 
 Reduction of acetophenone 29 and a simple ketimine with thiourea catalyst 
64 (20% catalyst loading) in both cases gave the product in 40% yield, however no 
enantioselectivity was observed.  Catalyst 65 proved to be less reactive in the 
reduction reactions, the observed yields were 20%, however some selectivity was 
observed for the reduction of acetophenone, 10% ee, highlighting the importance 
of having the thiourea moiety next to the stereogenic centre.  Reduction using 
histidine catalyst 66 did not proceed and only starting material was isolated.  
Disappointingly, none of the catalysts exhibited activity in the allylation of 
benzaldehyde; only 5% product was isolated for catalysts 64 and 66.   
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Entry Catalyst Yield (%) ee (%)
1
2
3
64
66
65
X
64
O
N-PMP
N-PMP
N-PMP
O 65
4
5
40 -
40 -
20 10
20 -
- -
HSiCl3, CHCl3, -20 
oC
Catalyst 20 mol%Ph Me
X
Ph Me
XH
*
 
Table 2.1: Reduction test reaction results. 
 
Entry Catalyst Yield (%) ee (%)
1
2
3
64
66
65
5
-
5
-
-
-
O
HPh
OH
Ph
Cl3Si
DIPEA, CHCl3, -20 
oC
Catalyst 20 mol%
*
 
Table 2.2: Allylation test reaction results. 
 
Although the thiourea catalysts were equally active for reduction of both 
ketones and ketimines the conversion was too low to be considered active enough 
to carry on.  It was thought that replacement of the thiourea-phenyl group with a 
3,5-trifluoromethylphenyl group would improve reactivity and selectivity through 
stabilisation of the thiourea conformation.   It has been shown that when the ortho 
hydrogen atoms are more positively polarized due to meta electron withdrawing 
groups they form hydrogen bonds to the sulfur atom hindering the rotation of the 
phenyl group (Scheme 2.10). This increases the rigidity of the structure and has 
been shown to increase the binding ability of the thiourea fragment.[71,72]  Attempts 
to introduce the 3,5-bistrifluoromethylphenyl group to the catalyst, as in 90, did not 
yield enough material to be used. Histidine derived catalyst 66 was not considered 
promising enough to be carried on, thus alternative structural motifs were sought.   
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Scheme 2.10: Attractive S-H interaction 
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2.5 Phosphoramide Targets 
 
 Phosphoramide groups can be used as a coordinating group alternative to 
formamides for activation of silicon reagents.  Our new catalyst design included this 
as well as an aromatic amide group to promote hydrogen bonding and possibly 
aromatic interactions between the catalyst and substrate.  A selection of intended 
catalyst structures is shown in Chart 2.2.  
 
HN
O
HN
P
O
N
O
HN
P
O
HN
O
HN
P
O
O
O
HN OH
P
O
P
O
N
H
92 93
94 95 96
HN
O
HN
P
O
91
O
O
 
Chart 2.2: Phosphoramide based catalysts. 
 
Initial catalytic tests were carried out using catalyst 91 which was assessed 
in the reduction of 29 and 89 and the allylation of benzaldehyde 6.  Additionally 91 
was also tested in the allylation of 2-hydroxyphenyl imine 97 following the 
publications by Kobayashi[73] and Tsoegova[74] (Scheme 2.11).   
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N
HO
HN
HO
*
Proline 2.5eq,
DIPEA, DCM
Catalyst 20 mol%
rt, 24h
SiCl3
H
O OH
Cl3Si
Catalyst
X XH
HSiCl3
Catalyst
29 X = O
89 X = NPMP
*
*
97 98
 
Scheme 2.11: Test reactions for proposed phosphoramide organocatalysts. 
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2.6 Synthesis 
 
 The synthesis of valine-derived organocatalysts 91 and 92 began with 
coupling of N-Boc valine, 70, to 3,5-dimethylaniline, 99, employing the mixed 
anhydride method to afford amide 100 (Scheme 2.12).  The resulting amide was 
then treated with TFA in DCM to remove the Boc protecting group.  Treatment of 
the deprotected material with diphenylphosphinic acid chloride and 
dimethylphosphinic acid chloride yielded 91 and 92 respectively.  Ligand 93 was 
synthesised in an analogous manner with benzhydrylamine, both 92 and 93 were 
available in our lab.  Treatment of 2,2’dihydroxy biphenyl with trichlorophosphine 
afforded 101.  Ligand 94 was obtained by treating amide 100 with 101 after Boc 
deprotection (Scheme 2.12). 
 Catalyst 95 was obtained in 67% yield by treating valinol, 84, with 
diphenylphosphinyl chloride (Scheme 2.13).  The synthesis of catalyst 96 
commenced with conversion of racemic binol to the corresponding phosphoryl 
chloride 102.  Treatment of 102 with (S)-methylbenzylamine, 103, generated the 
phosphoramide 96 in 70% overall yield.  Resolution of the diastereomers was 
carried out by recrystallisation from ethanol.  Finally, ligand 105 was synthesised 
from enantiopure diamine 104 and diphenylphosphinylchloride; recrystallisation 
from toluene afforded the pure phosphoramide in 72% yield (Scheme 2.13). 
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Scheme 2.12: Synthesis of Phosphorous containing ligands. 
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Scheme 2.13: Synthesis of diastereomeric phosphorous ligands. 
P a g e  | 48 
 
2.7 Allylation at C=N 
 
Allylation of imines is an important C-C bond forming reaction as it leads to 
the generation of chiral amines which represent synthetically useful intermediates 
for many applications.[75,76]  However, it is one of the few reactions that has 
remained solely in the realm of transition metal catalysis and to date there has 
been no publication of a true organocatalytic reaction for the allylation of 
aldimines.[2,18]  Recent advances are pushing closer to development of an 
organocatalytic protocol for this elusive reaction.[39,74]  Although not purely 
catalytic, some organic molecules have emerged as good activators of allylsilanes 
when employed in stoichiometric quantities.[2,18,39,74] 
 Work carried out by Kobayashi showed that allylation of acylhydrazones 
derived from aldehydes with allyltrichlorosilane could be achieved in the presence 
of neutral coordinate organocatalysts (NCOs).  It was shown that NCOs such as DMF 
and HMPA were able to efficiently promote the racemic reaction when used as 
solvent.[39]  Further development identified sulfoxides as another NCO capable of 
promoting the reaction; in particular the use of a chiral sulfoxide resulted in an 
asymmetric reaction taking place.[73]  By using chiral sulfoxide 107 at a loading of 
300 mol%, chiral amine derivative 108 was obtained in 73% yield and 93% ee 
(Scheme 2.14).  While N-acylhydrazones showed good reactivity in the allylation 
reaction, simple aldimines remained unreactive towards allyltrichlorosilanes.   
 
N
HPh
NHBz HN
Ph
NHBz
O
S
Me
Cl3Si
CH2Cl2
-78 oC, 1 h
108 73%, 93% ee106
107
 
Scheme 2.14: Asymmetric addition of allylsilanes to acylhydrazones with NCO’s. 
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 More recently a chiral bisformamide 109, (Chart 2.3) has emerged as a 
stoichiometric activator for the allylation of simple aldimines.[74]  Tsogoeva et al 
showed that aldimines derived from benzaldehyde and 2-aminophenol could be 
successfully converted to allylic amines by using allyltrichlorosilane in the presence 
of bisformamide 109 in conjunction with L-proline.  Homoallylic amines were 
formed in good yield (>89%) and high selectivity (≤85%), however 2 equivalents 
each of bisformamide 109 and L-proline are required (Table 2.3, entries 1 – 4).  It 
was suggested that proline forms a chiral silane reagent in situ, 113.  This silane 
complex is then able to coordinate both the imine through the aromatic hydroxyl 
group and bisformamide 109 to generate the chiral transition state (Figure 2.2).  In 
the absence of the 2-hydroxyl group no reaction occurs, supporting the interaction 
with silicon.  Further studies with monoformamides 110 (Chart 2.3) showed that 
the second formamide group is integral to the selectivity observed with 109[77].  
Based on these results, Tsogoeva proposed a transition state involving a 
hexacoordinate silicon species.  It was suggested that the imine was activated by 
forming a bond with silicon through the ortho-hydroxy group; coordination of a 
formamide moiety to silicon results in a hypervalent silicon species with enhanced 
nucleophilicity (Figure 2.2). 
 
HNNH
OO
N N
OO
H H
109
N
HO
O
N
H Ar
110a Ar = Ph
110b Ar = naphth  
Chart 2.3: Formamide catalysts developed by Tsogoeva. 
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X Yield (%) ee (%)
NO2
CF3
Cl
OMe
94
91
89
94
85
81
85
68
N
H
X
HO
HN
X
HO
Proline (2 eq), CH2Cl2
RT, 48h
SiCl3
Formamide (2 eq)
111 112
Entry
1
2
3
4
 
Table 2.3: Allylation of imines with allyltrichlorosilane and bis-formamide activator. 
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Figure 2.2: Transition state proposed by Tsogoeva 
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2.8 Applications in Model Catalytic Reactions 
 
 Phosphoramide 91 showed some promise in the allylation of aldimine 111 
with allyltrichlorosilane, forming the chiral amine in 51% yield and 40% ee with 
catalyst loading 20 mol% (Scheme 2.15).  Unfortunately, the catalyst 91 turned out 
to be inactive in the allylation of aldehydes or reduction of ketones and ketimines. 
 
 
Scheme 2.15: Organocatalytic allylation reactions with 91 as organocatalyst. 
 
 Variation in the temperature of the reaction identified room temperature as 
the optimum (Table 2.4).  Surprisingly, when the reaction mixture was cooled, 
selectivity also dropped.  It may be that at lower temperatures an uncatalysed 
reaction mechanism may be favoured over the more selective pathway.  The 
additive was found to be required for enantiodiscrimination (Table 2.5, entry 1).  A 
range of additives other than (L)-proline were also examined (Table 2.5).  In the 
presence of N-methyl imidazole, iso-propanol and dimethylaminopyridine the 
desired sec-amine was formed in moderate yields however the enantioselectivity 
was much lower than that observed for proline (Table 2.5, entries 2-4).  In the case 
of (D)-proline (Table 2.5, entry 5), the opposite enantiomer of sec-amine 112 was 
formed in good yield (61%) and similar selectivity (38%), indicating that proline is 
involved in the enantiodifferentiation process in the transition state.  Additionally 
the allylation of 111 did not proceed in the absence of di-isopropylethylamine. 
 
N
H
HNCl3Si
DIPEA, CHCl3
Catalyst 91 20 mol%
Proline 2.5 eq
112
51%, 40% ee
111
HO HO
HN
O
HN
P
O
91
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Entry Temperature (oC) Yield (%) ee (%)
1
2
3
-20
0
rt
N.A. N.A.
20 (S)
40 (S)
44
51
 
Table 2.4: Effects of temperature on catalytic allylation reaction. 
 
entry catalyst activator yield (%) ee (%)
1 91 none 44 0
2 91 NMI 58
3 91 iPrOH 59
4 91 (D)-proline 61
5 91 DMAP 20 0
13 (S)
11 (S)
38 (R)
 
Table 2.5: Activators for allylation reaction. 
 
After identifying a set of optimum conditions a range of other chiral 
nitrogen-phosphorous ligands were tested in the allylation of aldimine 111 (Table 
2.6). 
A number of structural changes were made to the parent catalyst 91 (Chart 
2.2).  Posphinamide 92 where Ph2P moiety was replaced with Me2P resulted in a 
significant decrease in selectivity.  Likewise, phosphate derivative 93 was active, 
however not as selective as 91.  The important role of the aromatic amide moiety 
present in 91 was demonstrated by the reduced selectivity observed with catalyst 
95, which produced only racemic product.  Attempts to tune selectivity by replacing 
the phenyl group with a larger aromatic moiety 93 were unsuccessful, resulting in a 
marginal drop in enantiodifferentiation.  Diastereomeric phosphoramides 96, 
derived from BINOL and 105, did not succeed in the formation of 112, identifying 91 
as the superlative phosphoramide organocatalyst tested. 
P a g e  | 53 
 
Entry Catalyst Yield (%) ee (%)
1
2
3
4
5
6
91
92
93
94
95
96
0
0
0
40 (S)
7 (S)
30 (S)
7 105 0
51
70
54
0
0
0
0
N
H
HNCl3Si
DIPEA, CHCl3
Catalyst 91 20 mol%
Proline 2.5 eq
112111
HO HO
 
Table 2.6: Effects of catalyst structure variation on catalytic allylation reaction. 
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2.9 Summary 
 
 Design and synthesis of a number of potential bifunctional organocatalysts 
incorporating imidazole, thiourea and phosphoramide moieties was successfully 
achieved.  The organocatalysts were tested in the allylation and reduction reactions 
of carbonyl compounds and imines. 
 The greatest success was achieved by valine derived phosphoramide 91 
which catalysed the allylation of imine 111 to homoallylic amine 112 in 40% ee with 
a loading of 20 mol%, the reaction hitherto reported only with the use of 
stoichiometric activators.  Our other bifunctional ligands did not show much 
promise in the model test reactions, however they may still find use in other 
catalytic processes, so further testing to reveal potential applications is required.  
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3 Quinoline Derived Organocatalysts 
 
3.1 Introduction and Target Compounds 
 
Reduction of prochiral ketones and imines is most commonly carried out in 
industry via asymmetric hydrogenation.  However this method is not free from 
problems, namely those associated with metal leaching, high pressure, and the cost 
of the catalyst and its regeneration.  The alternative metal-free protocols are rare, 
however high selectivity has been attained with the use of formamide derivatives 
and trichlorosilane.[58] 
As part of our group’s focus into Lewis-basic activators for silanes, (2-
pyridyl) oxazolines were identified as an efficient class of catalysts for the reduction 
of ketones with trichlorosilane.  A range of ketones were successfully converted to 
the corresponding secondary alcohols with high selectivity.[54]  The initial results 
also showed the catalysts 45 and 46 were effective for the reduction of a small 
range of aromatic ketimines (Scheme 3.1).   
 
N
N
O
N
N
O
Ph
Ph
O
X
OH
X
HSiCl3, CH2Cl2
Catalyst
45
29% conv
66% ee (R)
46
85% conv
78% ee (R)
*
 
Scheme 3.1: Reduction of ketones with 2-pyridyl oxazolines.  
 
Although catalyst 46 successfully reduced aromatic ketones and ketimines 
with high selectivity, in some cases it suffered from low conversion.  Subsequent 
studies showed that the catalyst decomposed under the reaction conditions.  
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Bidentate coordination of the catalyst to trichlorosilane generates a hexacoordinate 
silicon species, 113; a chloride can then dissociate to form a stable pentacoordinate 
silicon species, 114.  In this species, the Lewis acidic silicon activates the oxazoline 
towards nucleophilic attack.  The dissociated chloride is able to attack at the 
benzylic position and leads to opening of the oxazoline ring, 115 (Scheme 3.2).  
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HN O
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Scheme 3.2: Decomposition of oxazoline derived catalyst. 
 
 Amide 116 was isolated from the reaction mixture and its structure was 
confirmed by spectroscopic data.  The susceptibility of the oxazoline 5-position to 
nucleophilic attack is due in part to the electronegativity of oxygen.  It was 
proposed that replacing the oxazoline moiety with thiazoline would prevent 
chloride promoted ring-opening as the decreased electronegativity of sulfur should 
reduce the propensity for nucleophilic attack at the benzylic position. Further, it 
was considered that replacement of oxygen with either an N-methyl group or a CH2 
group could also prevent ring-opening.   
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Chart 3.1: Alternatives to the oxazoline moiety for prevention of ring-opening. 
 
 To this end, we identified structures 117 to 122 as alternatives to 46 that 
would not be as susceptible to ring opening (Chart 3.1).  Pyridine imidazoline 117 
was synthesized in our group and shown to be inferior to 46 as a promoter for the 
reduction of ketones.  Reduction of acetophenone 29 with 117 afforded alcohol 30 
in 17% conversion and 34% ee, compared with 40% conversion, 64% ee for the 
corresponding oxazoline under the same conditions.   
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3.2 Synthesis 
 
 The synthesis of (2-pyridyl) thiazoline derivatives 119 to 122 was based on 
generation of the general thioamide 124 through coupling with mandelic acid 
derivative 123 followed by cyclisation with mesyl chloride (Scheme 3.3). 
 
N
R H
N
OH
Ph
S
N
N
S
Ph
RMsCl, base
124123
HO
Ph
NH2
125
 
Scheme 3.3: General method for formation of thiazoline via cyclisation. 
 
 Amino alcohol 123 was generated from mandelic acid in a two-step process, 
according to the protocol developed by Brunner.[78] First, mandelic acid, 126, was 
converted to mandelamide 127 in 90% yield.  The resulting amide 127 was then 
reduced with lithium aluminium hydride in refluxing tetrahydrofuran to produce 
amino alcohol 123 in 84% yield (Scheme 3.4). 
 
Ph
HO
OH
O
Ph
HO
NH2
O
Ph
HO
NH2
1. AcCl, MeOH
0 oC - rt
2. NH4OH, MeOH
4 oC
LiAlH4, THF
reflux
127 90% 123 84%126
Scheme 3.4: Synthesis of mandelic acid derived amino alcohol. 
  
Synthesis of pyridyl-thiazoline derivative 119 began with generation of 
thioester 129 from 2-chloromethylpyridine, 128, sulfur and methyl iodide in 51% 
yield.  The resulting thioester was then coupled with amino alcohol 123 in THF in 
the presence of triethylamine.  Thioamide 130 was isolated in 78% yield.  
Cyclisation was then achieved by treating thioamide 130 with mesyl chloride, 
furnishing pyridine-thiazoline 119 in 82% yield as a white crystalline solid (Scheme 
3.5).   
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Scheme 3.5: Synthesis of 2-pyridyl thiazoline 
 
Synthesis of (2-quinolyl) thiazoline 122 was carried out in analogous manner 
to 119, beginning with generation of thioester 132 from 2-chloromethyl quinoline, 
131 (99%).  Thioester 132 was then coupled with amino alcohol 123 to yield 
thioamide 133 in 78% yield.  Cyclisation was again achieved by treating thioamide 
133 with mesyl chloride, furnishing 2-quinoline-thiazoline 122 as a black oil which 
yielded black crystals on recrystallisation from ethanol (77%, Scheme 3.6). 
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Scheme 3.6: Synthesis of 2-quinolinyl thiazoline 
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Taking into account that 1-chloromethylisoquinoline is not readily available; 
1-isoquinoline carboxylic acid, 135, was identified as an alternative starting 
material. It was thought that coupling of the acid with amino alcohol 123 followed 
by thionation would result in the desired thioamide 136.  Lawesson’s reagent, 134, 
was chosen because it was shown to be superior to P2S5 for conversion of carbonyl 
groups to thiocarbonyl groups (Scheme 3.7).[79,80]  Lawesson also showed that 
HMPA could act as a non-covalent protecting group to prevent thionation of 
alcohols, thus preventing an additional two steps being carried out to prevent 
undesired thionation of the hydroxyl group.   
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Scheme 3.7: Mechanism of action of Lawesson’s reagent 
 
Coupling of 1-isoquinoline carboxylic acid, 135, with amino alcohol 123 was 
carried out using the mixed anhydride method and produced the amide 136 in 89% 
yield (Scheme 3.8).  Thionation of the amide with Lawesson’s reagent was carried 
out in HMPA; however conversion to the desired thioamide 137 was very low, 
furthermore it could not be isolated from the crude reaction mixture.  It is known 
that thionation with Lawesson’s reagent is very sensitive to solvent and depends on 
the substrate therefore it was decided to investigate influence of different solvents.  
Toluene is known to be an efficient solvent for thionation using Lawesson’s 
reagent and so was chosen as a starting point for solvent investigations.  As HMPA 
would not be employed, the hydroxyl was protected with a TBS ether to afford 138 
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(63%).  The silylated compound was then subjected to Lawesson’s reagent in 
refluxing toluene overnight after which successful thionation was observed.  
Treatment of the crude reaction mixture with acid followed by column 
chromatography led to the isolation of desired catalyst 120 in 74% yield (Scheme 
3.8). 
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Scheme 3.8: Synthesis of 1-isoquinoline thiazoline 
 
 Synthesis of catalyst 121 was first attempted employing the same method 
used for 1-isoquinoline derivative 120.  Coupling of 3-isoquinoline carboxylic acid 
139 to mandelamine 123 was achieved using the mixed anhydride method and the 
target molecule, 140, was isolated in 43% yield.  Protection of the hydroxyl group 
was then carried out with TBDMSCl furnishing the protected compound 141 in 59% 
yield.  On treatment with Lawesson’s reagent in refluxing toluene however, the only 
material recovered was amide 140 (Scheme 3.9).   
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Scheme 3.9: Synthesis of 3-isoquinoline thiazoline, strategy 1. 
 
 An alternative strategy beginning with 3-methyl isoquinoline 142 as a 
precursor was employed (Scheme 3.10).  Conversion of 3-methyl isoquinoline, 142, 
to thioester 144 was achieved by chlorination with trichlorisocyanuric acid in 
refluxing chloroform followed by treatment with sulphur and methyl iodide.  
Thioester 144 was then coupled to mandelamine 123 to produce thioamide 145 in 
50% yield.  Thioamide 145 was then treated with mesyl chloride in the presence of 
triethylamine to affect cyclisation.  The cyclisation did not proceed as well as 
anticipated, however enough of the target thiazoline 121 (5%) was isolated to allow 
catalytic screening (Scheme 3.10). 
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Scheme 3.10: Synthesis of 3-isoquinoline thiazoline, strategy 2.  
 
 To allow comparison with thiazoline catalyst, an oxazoline analogue 148 was 
prepared.[54]  Synthesis of 1-isoquinoline oxazoline, 148, commenced with coupling 
of 1-isoquinoline carboxylic acid 146 to mandelamine 123 using the mixed 
anhydride method.  The resulting amide 147 was formed in 89% yield and isolated 
as a white crystalline solid.  Amide 147 was then treated with mesyl chloride in the 
presence of triethylamine to affect cyclisation.  The desired 1-isoquinoline oxazoline 
148 was recrystallised from ethanol and isolated as a white solid in 95% yield 
(Scheme 3.11).  
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Scheme 3.11: Synthesis of 1-isoquinoline oxazoline. 
 
 Finally, synthesis of pyrroline catalyst 118 was attempted.  It was proposed 
that intramolecular condensation of 1,4-amino-ketone 149 would yield the desired 
pyrroline 118.  Aldol condensation of 2-acetyl pyridine, 152, and benzaldehyde, 6, 
to generate 151, followed by Michael addition of nitromethane, would form a 
suitable starting material for formation of 1,4-amino-ketone 149 (Scheme 3.12). 
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Scheme 3.12: Retrosynthetic analysis of 2-pyridine pyrroline. 
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 Synthesis of 2-pyridine pyrroline 118 commenced with aldol condensation 
of acetyl pyridine, 152, and benzaldehyde, 6, in aqueous sodium hydroxide to 
afford 151 in 35% yield (Scheme 3.13).  Michael addition of nitromethane to 151 in 
methanol resulted in the nitro compound 150 (41%).  Reduction of the nitro group 
had to be carried out selectively to prevent unwanted reduction of the ketone 
group. Initial reduction of the nitro group with SnCl2 did not result in formation of 
149 and only starting material was isolated.  Attempts to reduce 150 with NaBH4 or 
by hydrogenation were equally unsuccessful.  Further attempts at reduction with 
the more reactive species NiCl2/NaBH4 resulted in over-reduction to amino alcohol 
153.  Although 153 was formed in 98% yield, re-oxidation to the ketone was 
unsuccessful. 
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Scheme 3.13: Synthesis of 2-pyridine pyrroline 
 
 It was believed that protection of the ketone before treatment with 
NaBH4/NiCl2 would prevent over-reduction; however attempts to form the 
protected ketone 154 were unsuccessful (Scheme 3.14).  We then attempted to re-
oxidise the fully reduced amino alcohol 153, first protecting the amino group.    
Attempts to protect the amino functionality with a Boc group, 156, in order to allow 
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oxidation of the alcohol to ketone however, did not produce the desired products 
(Scheme 3.14). At this point the synthesis of 118 was discontinued. 
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Scheme 3.14: Protection of ketone and amino groups. 
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3.3 Applications in Organocatalytic Reduction Reactions 
 
Prospective thiazoline activators 119 to 122 were tested in the 
organocatalytic reduction of acetophenone 29 and simple ketimine 89 (Scheme 
3.15).  After completion the reaction mixtures were analysed by chiral GC and NMR 
to evaluate enantioselectivity and catalyst degradation.  
 
X XH
Thiazoline (20 mol%)
HSiCl3, CHCl3
29 X = O
89 X = N-PMP
*
 
Scheme 3.15: Model catalytic reactions. 
 
Pyridine derived thiazoline 119 showed promising initial results; 
phenylethanol, 30, was obtained in 25% yield and 64% ee.  Chiral amine 89 was also 
isolated in reasonable yield, 29%, and selectivity of 28% ee (Table 3.1, entries 1 and 
2).  Analysis of the reaction mixture after work up by 1H NMR showed that the 
thiazoline catalyst 119 had remained intact and was not degraded. However, the 
reactivity of the thiazoline catalyst was considerably reduced compared to the 
related oxazoline, 46. 
The addition of further steric constraints from the quinoline and 
isoquinoline fragments reduced the activity of the thiazoline derived 
organocatalysts even further.  Thiazolines 120 and 122 derived from 1-isoquinoline 
and 2-quinoline were unsuccessful in the reduction of both ketones and ketimines.  
Thiazoline 121 obtained from 3-isoquinoline showed some activity in the reduction 
of acetophenone (~5% conversion), however was inactive in the reduction of 
ketimines (Table 3.1).  Oxazoline catalyst 148 however performed well in the 
reduction of both acetophenone 29 and ketimines (Table 3.1, entries 9 and 10) 
although some degradation product was observed.  It may be that 120 does not 
allow efficient coordination of the silane due to the extra aromatic steric constraints 
while the increased size of sulfur compared to oxygen, forced the rings out of plane 
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in the case of 122.  Thiazoline 121 may allow weak coordination to the silane 
however apparently it remains insufficient to successfully activate trichlorosilane 
towards reduction.   
 
Yield (%) ee (%)Entry Catalyst X
1
2
3
4
5
6
7
8
120
119
119
120
121
121
122
122
O
N-PMP
O
O
O
N-PMP
N-PMP
N-PMP
0
0
0
0
0
0
N.A.
N.A.
N.A.
N.A.
N.A.
N.A.
25 64
29 28
HSiCl3, CHCl3
Catalyst 
20 mol%
X XH
9 148 O 96a 81b
10 148 N-PMP 60 85b
aConversion determined by GC after standard reaction work-up; bpreviously reported results[54]
*
Table 3.1: Reduction with ligands 119 –122, 148. 
 
Based on these results it is believed that catalysts 120 and 122 do not 
permit favourable coordination of the silane whereas 3-isoquinoline derived 
catalyst 121 was not sufficiently active to promote reduction of ketones and 
ketimines.  Pyridine thiazoline 119, although successful, proved to be too sluggish to 
be further investigated.  The initial results, however, show that 1-isoquinoline 
oxazoline 148 is a superior organocatalyst for the reduction of ketones and 
ketimines.  It was decided to carry out further studies with organocatalyst 148 in 
order to expand the substrate range and investigate the scope of the reaction. 
 A range of α-chloro and heterocyclic ketones and ketimines were subjected 
to reduction with trichlorosilane in the presence of oxazoline 148 (Table 3.2).  
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Ketones and imines derived from α-chloro acetophenone after reduction to the 
corresponding alcohols and amines can be cyclised into the corresponding epoxides 
and aziridines.  Reduction of heterocyclic ketones or imines allows easy generation 
of chiral alcohols and amines finding application as chiral building blocks and 
synthetic intermediates in target synthesis.   
 Reduction of a range of ketones was carried out with 20 mol% of oxazoline 
catalyst 148 in CHCl3 using HSiCl3 as the reducing agent.  Only 2-acetylthiophene 
and 2-methyl-5-acetylfuran exhibited reasonable reactivity, although the resulting 
alcohols were found to be racemic (Table 3.2, entries 1 and 2).  Unfortunately, no 
product was formed with other ketones tried (Table 3.2, entries 3 – 8).  It is possible 
that the Lewis basic heteroatom in the tested heterocyclic ketones coordinates to 
silane interfering with the catalytic process and preventing reduction from 
occurring. 
 
O
R
OH
R
REntry Conversion (%) ee (%)
2-pyridine
4-pyridine
2-thiophene
2-thiazole
X X
Ph
2,5-dimethyl-3-furan
2-methyl-5-furan
1-(benzofuran-2-yl)
X
Cl
H
H
H
H
H
H
H
1
2
3
4
5
6
7
8
70
- -
Catalyst 148 20 mol%
HSiCl3
50
- -
- -
- -
- -
- -
0
0
9a 2-MeO-C6H4 H 50 87
10a 2-F-C6H4 H 35 70
11a Ph H 85 84
aPreviously reported results[54]
*CHCl3, -20 
oC
Table 3.2: Reduction of prochiral ketones with thiazoline 148. 
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Figure 3.1: Proposed transition state for catalysts 119 – 122, 148 
 
 Reduction of prochiral imines was more successful.  It was carried out in 
CHCl3 with 20 mol% of oxazoline catalyst 148 using HSiCl3 as the reducing agent.  
Propiophenone was reduced in 90% yield and 79% ee (Table 3.3, entry1). Chiral α-
chloro amines were obtained in 88 to 89% ee and good yield; 47% to 90% (Table 
3.3, entries 2-4).  Furan and thiophene derived imines were successfully reduced in 
73% yield, 55% ee and 77% yield, 60% ee respectively (Table 3.3, entries 5 and 6).  
Even imine derived from pyridine was successfully transformed to its corresponding 
amine in 41% yield and 82% ee (Table 3.3, entry 7).  The results obtained are 
consistent with our current theory of enantiodifferentiation (Figure 3.2).[54] 
 
N N
O
Ph
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Cl Cl
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Me
N
*
Ar
 
Figure 3.2: Proposed transition state for reduction of ketimines with 148. 
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R1 R2 Yield (%) ee (%)
phenyl CH2Cl
CH2Cl
CH2Cl
1-chloro-4-benzene
1-fluoro-4-benzene
2-furan Me
2-thiophene Me
phenyl Et
Entry
1
2
3
4
5
6
7
8
79
88
88
89
55
60
4-pyridine Me 82
N
R2R1
PMP
HN
R2R1
PMPHSiCl3, CHCl3
Catalyst 148
20 mol%
47
70
Me 7588
77
90
41
73
90
*
2-pyridine
Table 3.3: Reduction of prochiral ketimines with oxazoline 148.   
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3.4 Summary 
 
 Thiazoline catalysts derived from 2-pyridines have been shown to be 
effective activators of trichlorosilane for the reduction of ketones and ketimines.  
The problem of chloride promoted ring opening of the catalyst can be successfully 
avoided however at the cost of catalyst activity and selectivity.   
 Due to the lower reactivity of the thiazoline catalysts, further investigation 
was carried out with oxazoline catalyst 148.  Catalyst 148 was shown to be an 
efficient organocatalyst for the reduction of a range of ketimines with a large 
substrate scope.  The reactivity observed was in line with our previous mechanistic 
proposals.  
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4 Experimental 
 
General Methods 
 
All reactions were carried out under an inert atmosphere in oven-dried 
glassware unless otherwise stated.  Room temperature refers to ambient room 
temperature (20-22 oC); 0 oC refers to an ice slush bath.  Heated experiments were 
conducted using thermostatically controlled oil baths.  Reactions were monitored 
by Thin Layer Chromatography using aluminium backed silica gel 60 (F254) plates, 
visualised using UV254/286 nm and PMA, Dragendorf, Platinum and Ninhydrin dips as 
appropriate.  Flash chromatography was carried out using 60 Å silica gel as the 
stationary phase.   
Melting points were determined on a Kofler block and are uncorrected.  
Optical rotations were recorded in CHCl3 at 25 °C unless otherwise indicated, with 
an error of ≤±0.1.  The [α]D values are given in 10
-1
 deg cm
3
 g
-1
.  The NMR spectra 
were recorded in CDCl3, 
1
H at 400 MHz and 
13
C at 100.6 MHz on a Bruker 
Spectrospin 400 (400 MHz) spectrometer.  Chemical shifts are reported in δ units, 
parts per million with chloroform-d1 (δ 7.26, 
1
H; δ 77.0, 
13
C) as internal standard 
unless otherwise indicated.  Coupling constants (J) are measured in Hz and are 
unadjusted; therefore due to limits in resolution, in some cases there are small 
differences (<1 Hz) in the measured J value of some coupling constants.   The IR 
spectra were recorded on a JASCO FT-IR spectrophotometer for a thin film between 
NaCl plates.  The mass spectra (EI, CI and/or FAB) were measured on a Joel JMS700 
spectrometer.   
 Enantiomeric excess was determined by chiral GC analysis (using a 
Hewlett Packard 6890 Series GC system, Hewlett Packard 3395 integrator and 
Supelco α-DexTM or Supelco β-DexTM column) or by chiral HPLC analysis (using a 
Hewlett Packard Agilent 1100 Series quarternary pump, vacuum degasser, diode 
array detector, manual injector and Hewlett Packard ChemStation).  The chiral GC 
and HPLC methods were calibrated with the corresponding racemic mixtures. 
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 Imines used for catalytic reduction reactions were available in the 
laboratory and were synthesised using known methods. 
 
Bifunctional Organocatalysts 
 
HNN
O
HN
S
12
3
4
5
6
7
8 9
10 11
12
10 11
 
 
(S)-(-)-N-Methyl-N-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-propyl]-formamide 
(64): To a solution of N-(1-Aminomethyl-2-methyl-propyl)-N-methyl-formamide 
(524 mg, 1.88 mmol) in CH2Cl2 was slowly added phenylisothiocyanate (0.26 mL, 2.0 
mmol).  The reaction mixture was allowed to stir at room temperature overnight.  
The solvent was then removed in vacuo.  The crude mixture was then purified on a 
column of silica gel with a CH2Cl2-MeOH mixture (5:1) to afford 64 as a colourless oil 
(56%): [α]D -65.20 (c = 0.75, CHCl3/MeOH, 3:1); 
1
H NMR (400MHz, CDCl3) δH 0.78 
(3H, d, J3-H,4-H = 6.4 Hz, 4-H), 0.93 (3H, d, J3-H,5-H = 6.2 Hz, 5-H), 1.65 – 1.74 (1H, m, 3-
H), 2.61 (3H, s, 7-H), 3.63 - 3.70 (2H, m, 1-H), 4.10 – 4.17 (1H, m, 2-H), 7.08 – 7.14 
(2H, m), 7.29 – 7.45 (2H, m), 7.54 (1H, bs); 13C NMR (100MHz, CDCl3) δC 16.7 (CH3, 
4-C), 19.0 (CH3, 5-C), 27.7 (CH, 3-C), 32.5 (CH3, 7-C), 42.7 (CH2, 1-C), 64.9 (2-C), 124.8 
(CH), 126.6 (CH), 129.4 (CH), 137.2 (C, 9-C), 175.9 (CH, 6-C), 182.2 (C, 8-C); MS CI 
m/z (%) 280.3 (100, M+H), 246.3 (44), 218.3 (18), 163.1 (38), 145.2 (30); HRMS (CI) 
280.1484 (C14H22N3OS requires 280.1483. 
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HN HN
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8 9
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9
10
 
 
(S)-(-)-N-[3-Methyl-2-(3-phenyl-thioureido)-butyl] formamide (S)-(-)-65: (S)-88 
(736 mg, 3.2 mmol) was dissolved in a CH2Cl2-TFA (2:1) mixture (15 mL) and stirred 
at room temperature for 1 h.  The reaction mixture was then poured into saturated 
NaHCO3 solution (25 mL) and extracted with CH2Cl2 (3 x 20 mL).  The aqueous layer 
was then evaporated to dryness and the resulting solid extracted three times with 
CH2Cl2.  The organic layer was concentrated in vacuo and the residue dissolved in 
dry CH2Cl2 to which was added phenyl isothiocyanate (0.4 mL, 3.3 mmol) and the 
reaction was allowed to stir at room temperature overnight.  The solvent was then 
removed in vacuo and the crude residue purified on a column of silica gel with a 
Petrol – EtOAc mixture (3:2).  The product was then recrystallised from 
hexane/EtOAc to afford (S)-(-)-65 as an off white solid (100 mg, 12%): [α]D -96.6 (c 
1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3) δH 0.81 (d, J4-H,3-H = 7.1 Hz, 3H, 4-H), 0.88 (d, 
J5-H,3-H = 6.8 Hz, 3H, 5-H), 1.75 – 1.81 (m, 1H, 3-H), 3.18 – 3.23 (m, 1H, 1α-H), 3.45 – 
3.49 (m, 1H, 1β-H), 4.06 – 4.22 (m, 1H, 2-H), 5.99 (d, J = 9.1 Hz, 1H, 2-NH), 6.52 (bs, 
1H, 1-NH), 7.16 (d, J = 8.3 Hz, 2H), 7.24 – 7.35 (m, 1H), 7.37 – 7.42 (m, 1H), 8.12 (s, 
1H, 6-H); 13C NMR (100MHz, CDCl3) δC 18.3 (CH3, 4-C), 19.3 (CH3, 5-C), 30.8 (CH, 3-
C), 41.5 (CH2, 1-C), 59.5 (CH, 2-C), 125.7 (CH), 127.9 (CH), 130.3 (8-C), 130.4 (CH), 
161.9 (6-C), 181.69 (7-C). 
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(S)-N-(3,5-Dimethyl-phenyl)-2-formylamino-3-(τ-methyl-1H-imidazol-4-yl)-
propionamide (S)-66:  A solution of (S)-69 and trifluoroacetic acid (5 mL) in 
dichloromethane (5 mL) was stirred at room temperature for 1 h. The solvent was 
evaporated in vacuo and the crude TFA salt was dissolved in formic acid (5 mL).  
Acetic anhydride (2.5 mL) was added and the solution was allowed to stir at room 
temperature for 72 h. The mixture was then evaporated to dryness and the crude 
product was purified by chromatography on a column of silica gel (60g) with a 
CH2Cl2–MeOH mixture (5:1) to afford (S)-66 (100 mg, 59%) as an orange solid: [α]D 
0.0 (c 1.0, CHCl3)
[81]; 1H NMR (400 MHz, CDCl3) δH 2.21 (6H, s, 15-H), 2.94 (1H, dd, 
J3α-H, 3β-H  = 15.2 Hz, J3α-H, 2-H = 7.2 Hz, 3α-H), 3.11 (1H, dd, J3α-H, 3β-H = 15.2 Hz, J3β-H, 2-H 
= 4.0 Hz, 3β-H), 3.59, (3H, s, 10-H), 4.77 (1H, bd, J3β-H, 2-H = 4.0 Hz, 2-H), 6.66 (1H, s, 
5-H), 6.73 (1H, s, 7-H), 7.10 (2H, s, 12-H), 7.39 (1H, s, 14-H), 7.64 (1H, bs, 2-NH), 8.24 
(1H, s, 1-NH), 9.83 (1H, bs, 9-H); 13C NMR (100 MHz, CDCl3) δC 21.4 (CH3, 15-C), 29.7 
(CH2, 3-C), 33.7 (CH3, 10-C), 52.5 (CH, 2-C), 117.6 (CH, 5-C), 118.3 (CH, 7-C), 126.0 
(CH), 138.6 (C), 161.4 (CH), 168.82 (9-C); IR (NaCl) ν 3019, 2399, 1215 cm-1; MS (CI) 
m/z (%) 318.29 (100, M + NH4). 
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(S)-(+)-N-τ-Me-N-α-Boc-Histidine (S)-(+)-68
[70]: Sodium hydride (705 mg, 29.4 
mmol) was placed in a two-neck flask, flushed with Ar, washed 3× with petroleum 
ether, and dried under vacuum. The dry NaH was then added slowly to a 
suspension of N-α-Boc-histidine 67 (2.5 g, 9.8 mmol) in CH3CN at –15 
oC and stirred 
for 30 min. Methyl iodide (1.53 g, 10.7 mmol) was added and the reaction mixture 
was then heated to –5 oC and allowed to stir overnight at this temperature. The 
reaction was quenched with excess MeOH and the solvent was removed on a rotary 
evaporator. The resulting solid was then extracted with CHCl3 (3 × 50 mL), the 
solvent was evaporated and the resulting solid was purified by chromatography on 
a column of silica gel (50g), with a CH2Cl2–MeOH mixture (5:1), to give N-τ-Me-N-α-
Boc-Histidine (S)-(+)-68 as a pale yellow solid (1.64 g, 66%): mp (decomposition) 
166-168 oC; [α]D
25 +29.5 (c 1.0, CHCl3); 
1
H NMR (400 MHz, DMSO-d6) δH 1.36 (9H, s, 
11-H) 2.82 (2H, d, J = 4.8 Hz, 3-H) 3.56 (3H, s, 12-H) 3.91 (1H, bs, 2-H) 6.17 (1H, d, J = 
5.6 Hz, 5-H), 6.77 (1H, s, 7-H) 7.49 (1H, s, NH) in accordance with literature.[70] 
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(S)-(+)-[1-(3,5-Dimethyl-phenylcarbamoyl)-2-(1-methyl-1H-imidazol-4-yl)-ethyl]-
carbamic acid tert-butyl ester (S)-(+)-69:  
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Mixed anhydride method: 
N-τ-Me-N-α-Boc-Histidine (S)-(+)-68 (600mg, 2.3 mmol) and triethylamine (0.38 mL, 
2.8 mmol) were dissolved in THF and cooled to 0oC.  Methylchloroformate (0.27 mL, 
2.8mmol) was then added drop wise and the reaction allowed to stir for 1 hour.  
The precipitate was then filtered off.  Triethylamine (0.38 ml, 2.8 mmol) and 3,5-
dimethylaniline (0.35 ml, 2.8 mmol) were added and the reaction mixture left to stir 
overnight.  No product was observed. 
 
DCC Coupling Method: 
N-τ-Me-N-α-Boc-Histidine (S)-(+)-68 (200 mg, 0.76 mmol) was dissolved in CH2Cl2 
and a solution of DCC (190 mg, 0.92 mmol) in CH2CL2 (2 mL) was added.  3,5-
dimethylaniline (130 mg, 1.07 mmol) was slowly added and the reaction mixture 
was left to stir overnight.  Although formation of the desired product was observed, 
it was found to be inseparable from DCU, the reaction by-product. 
 
EDC.HCL Coupling Method: 
Prepared by modification of the procedure developed by Rosenberg.[82]  3,5-
dimethylaniline (95 mg, 0.79 mmol) was dissolved in DMF (5 mL).  N-τ-Me-N-α-Boc-
Histidine (S)-(+)-68 (200 mg, 0.76 mmol), 1-hydroxybenzotriazole hydrate (233 mg, 
1.7 mmol) and 4-methylmorpholine (96 mg, 0.91 mmol) were added sequentially.  
The reaction mixture was then cooled to –23 oC, 1-(3-dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride (226 mg, 1.14 mmol) added and the reaction 
allowed to stir for two hours.  The reaction was then heated to room temperature 
and left to stir overnight.  The reaction mixture was then poured into saturated 
NaHCO3 solution and extracted 3x with EtOAc.  The organic layer was then washed 
with water and brine and dried over MgSO4.  The solvent was removed and the 
crude mixture purified by column chromatography (PE:EtOAc 5:1).  The product (S)-
(+)-69 was obtained as yellow crystals in 65% yield.  
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EDAC Coupling Method: 
3,5-Dimethylaniline, (472 mg, 3.9 mmol) was added to a solution of N-τ-Me-N-α-
Boc-Histidine (S)-(+)-68 (1.0 g, 3.9 mmol), in dry MeCN. The solution was cooled to 
0 oC and EDAC.HCl (910 mg, 4.7 mmol) was added and the reaction mixture was 
allowed to stir at room temperature for 48 h.  The mixture was then poured into 
saturated NaHCO3 solution and extracted 3× with EtOAc. The organic layer was 
washed with water and brine and dried over MgSO4.  The solvent was evaporated in 
vacuo and the crude product was purified by chromatography on a column of silica 
gel (75g) with a CH2Cl2–MeOH mixture (5:1) to afford (S)-(+)-69 as a pale orange 
solid (896mg, 60%): [α]D +53 (c 1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3) δH 1.38 (9H, s, 
11-H), 2.20 (6H, s, 17-H), 2.91 (1H, dd, J3α-H, 3β-H = 15.6 Hz, J3α-H, 2-H = 6.4 Hz, 3α-H), 
3.05 (d, J3α-H, 3β-H = 15.6 Hz, J3β-H, 2-H = 2H), 3.64 (3H, s, 12-H), 4.46 (1H, s, 2-H), 6.23 
(1H, s,), 6.65 (1H, s, 5-H), 6.67 (1H, s, 7-H), 7.19 (2H, s, 14-H), 7.37 (1H, s, 16-H); 13C 
NMR (100 MHz, CDCl3) δC 21.4 (CH3, 17-C), 28.3 (CH3, 11-C), 30.7 (CH2, 3-C), 33.4 
(CH3, 12-C), 50.4 (CH, 2-C), 80.0 (10-C), 117.6 (CH, 5-C), 118.6 (CH, 7-C), 125.9 (CH, 
16-C), 137.2 (CH, 14-C), 138.5 (15-C), 155.1 (9-C), 170.2 (1-C). 
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(S)-N-methyl valinol (S)-71: To a suspension of LiAlH4 (3.8 g, 0.1 mol) in THF (60 mL) 
at 0 oC was slowly added N-Boc valine (5.0 g, 23.0 mmol) The reaction was allowed 
to stir at this temperature for 2h and was then heated overnight at 70 oC.  The 
mixture was then cooled to 0 oC, NaSO4.10H2O was added to remove excess LiAlH4 
and the mixture was then filtered through Celite.  The solvent was then removed in 
vacuo to afford N-methyl valinol as a colourless oil (2.36 g, 87%): 1H NMR (400 MHz, 
CDCl3) δH 0.82 (3H, d, J4-H,5-H = 6.8 Hz, 4-H), 0.89 (3H, d, J4-H,5-H = 6.8 Hz, 5-H), 2.35 
(3H, s, 6-H), 3.26 (1H, dd, J = 7.2 Hz, J1α-H,1β-H = 10.8 Hz, 1α-H), 3.55 (1H, dd, J = 4.4 
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Hz, J1α-H,1β-H = 10.8 Hz, 1β-H), 3.69 (1H, t, J = 6.8 Hz, 2-H) in agreement with 
literature.[83]  
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(S)-(-)-N-methyl-N-tert-butoxycarbonyl valinol (S)-72: To a solution of di-tert-butyl-
dicarbonate in CH2Cl2 (25 mL) at 0 
oC was added N-methyl valinol (2.36 g, 20.1 
mmol) and triethylamine (6.2 mL, 44.22 mmol).  The reaction mixture was allowed 
to warm to room temperature and left to stir overnight.  The reaction mixture was 
then acidified to pH 5 with 1M citric acid and extracted with CH2Cl2 (3 x 25 mL).  The 
organic phase was then dried over MgSO4 and evaporated to dryness.  The crude 
mixture was then purified on a column of silica gel with a Pet Ether-EtOAc mixture 
(2:1) to afford (S)-N-methyl-N-tert-butoxycarbonyl valinol as a colourless oil (3.8 g, 
87%): [α]D -25.00 (c = 1.0, CHCl3);  
1
H NMR (400 MHz, CDCl3) δH 0.81 (3H, d, J4-H,5-H = 
6.8 Hz, 4-H), 0.90 (3H, d, J4-H,5-H = 6.8 Hz, 5-H), 1.47 (9H, s, 9-H), 1.8 (1H, m, 3-H), 
2.69 (3H, s, 6-H), 3.40 – 3.48 (1H, m), 3.60 – 3.69 (1H, m), 3.91 – 4.23 (1H, m); CI MS 
m/z (%) 218.2 (20, M+H), 162.1 (100), 118.2 (18); HRMS (CI+) 218.1756 (C11H24O3N 
requires 218.1758). 
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 (S)-(1-Aminomethyl-2-methyl-propyl)-methyl-carbamic acid tert-butyl ester (S)-
73: To a dry round bottomed flask was added phthalimide (2.04 g, 13.88 mmol), 
THF (25 mL), triphenylphosphine (7.28 g, 27.75 mmol) and N-methyl-N-tert-
butoxycarbonyl valinol (2.0 g, 9.25 mmol) in that order.  The mixture was cooled to 
0oC and diethylazodicarboxylate (4.02 g, 23.12 mmol) added.  The reaction mixture 
was warmed to rt and allowed to stir overnight.  The solvent was then removed in 
vacuo and the residue passed through a column of silica gel with a Pet Ether-EtOAc 
mixture (5:1).  1H NMR (400 MHz, CDCl3) δH 0.78 – 1.19 (m, 15H), 1.72 (bs, 1H), 2.55 
(s, 3H), 3.61 – 3.72 (m, 2H), 3.95 (m, 1H), 7.52 – 7.61 (m, 2H), 7.70 – 7.80 (m, 2H). 
To a solution of the crude material in EtOH (5 mL) was added hydrazine hydrate 
(1.44 g, 45.0 mmol).  The reaction mixture was allowed to stir overnight at room 
temperature.  The reaction mixture was then filtered and washed with Et2O, the 
solvent was removed in vacuo to afford (1-Aminomethyl-2-methyl-propyl)-methyl-
carbamic acid tert-butyl ester as an off white solid (99%). 1H NMR (400 MHz, CDCl3) 
δH 0.85 (3H, dd, J = 2.0 Hz, J = 6.4 Hz, 4-H), 0.99 (3H, dd, J = 6.0 Hz, J = 6.8 Hz, 5-H), 
1.49 (9H, s, 9-H), 1.65 (1H, m, 3-H), 2.73, 2.80 (2 x s, 2 x 3H), 2.93 (1H, dd, J = 4.4 Hz, 
J = 12.4 Hz, 1α-H), 2.98 (1H, dd, J = 3.6 Hz, J = 13.6 Hz, 1β-H), 3.78 (1H, m, 2-H). 
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(S)-(-)-Methyl-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-propyl]-carbamic acid 
tert-butyl ester (S)-74: To a solution of (1-Aminomethyl-2-methyl-propyl)-methyl-
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carbamic acid tert-butyl ester (S)-73 (1.61 g, 4.60 mmol) in Et2O was slowly added 
phenylisothiocyanate (676 mg, 5.0 mmol).  The reaction mixture was allowed to stir 
at room temperature overnight.  The solvent was then removed in vacuo and the 
crude product purified purified on a column of silica gel with a Pet Ether-EtOAc 
mixture (2:1) to afford (S)-74 (1.43 g, 88%) as a white solid: [α]D -29.9 (c = 1.0, 
CHCl3);  
1
H NMR (400 MHz, CDCl3) δH 0.75 (3H, d, J4-H, 3-H = 6.8 Hz, 4-H), 0.95 (3H, d, 
J5-H, 3-H = 6.8 Hz, 5-H), 1.27 (9H, s, 9-H), 1.70 (1H, m, 3-H), 2.62 (3H, s, 6-H), 3.72 (2H, 
m, 1-H), 4.02 (1H, m, 2-H), 7.08 – 7.12 (2H, m, 12-H), 7.20 - 7.33 (3H, m, 13-H, 14-
H); CI MS m/z (%)  352.3 (82, M+H), 218.3 (100); HRMS (CI) 352.2059 (C18H30N3O2S 
requires 352.2061). 
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(S)-2,2,2-Trifluoro-N-methyl-N-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-
propyl]-acetamide (S)-75: Methyl-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-
propyl]-carbamic acid tert-butyl ester (S)-74 (98 mg, 0.28 mmol) was dissolved in a 
CH2Cl2-TFA (2:1) mixture (5 mL) and stirred at room temperature for 1 hour.  The 
solvent was then removed in vacuo.  The crude TFA salt was dissolved in formic acid 
(1 mL) and acetic anhydride (224 mg, 2.2 mmol) added and the reaction mixture 
was allowed to stir for 16h.  The solvent was then removed in vacuo and the crude 
residue purified on a column of silica gel with a Pet Ether – EtOAc mixture (2:1) to 
afford (S)-75 as a white solid (62 mg, 64%):  1H NMR (400 MHz, CDCl3) δH 0.96 (3H, 
d, J4-H, 3-H = 6.8 Hz, 4-H), 1.05 (3H, d, J5-H, 3-H = 6.8 Hz), 2.05 (1H, m, 3-H), 2.56 (3H, s, 
6-H), 3.41 (1H, m, 1α-H), 3.51 (1H, m, 1β-H), 4.10 (1H, m, 2-H), 7.07 – 7.26 (5H, m), 
7.79 (1H, bs, 9-NH), 8.63 (1H, bs, 11-NH);  13C NMR (100 MHz, CDCl3) δC 16.8 (CH3, 
4-C), 19.1 (CH3, 5-C), 27.7 (CH, 3-C), 32.4 (CH3, 6-C), 42.6 (CH2, 1-C), 64.9 (CH, 2-C), 
124.8 (CH), 126.5 (CH), 129.3 (CH), 137.3 (C), 162.5 (C, 7-C), 182.2 (C, 10-C). 
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(S)-N-Methyl-N-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-propyl]-acetamide 
(S)-76: Methyl-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-propyl]-carbamic acid 
tert-butyl ester (S)-74 (1.43 g, 4.07 mmol)  was dissolved in a CH2Cl2-TFA (2:1) 
mixture (10 mL) and stirred at room temperature for 1 hour.  The solvent was then 
removed in vacuo.  The crude TFA salt was dissolved in formic acid (10 mL) and 
acetic anhydride (3.32 g, 32.6 mmol) added and the reaction mixture was allowed 
to stir for 16h.  The solvent was then removed in vacuo and the crude residue 
purified on a column of silica gel with a Pet Ether – EtOAc mixture (5:1) to afford N-
Methyl-N-[2-methyl-1-[(3-phenyl-thioureido)-methyl]-propyl]-acetamide as a 
yellow oil: 1H NMR (400 MHz, CDCl3) δH 1.05 (3H, d, J4-H, 3-H = 6.8 Hz, 4-H), 1.12 (3H, 
d, J5-H, 3-H = 6.8 Hz, 5-H), 1.99 (3H, s, 8-H), 2.11 (1H, m, 3-H), 2.18 (3H, s, 6-H), 3.44 
(1H, bs, 1α-H), 3.62 (2H, m, 1β-H, 2-H), 7.17 – 7.41 (m, 5H), 8.29 (1H, bs, 9-NH), 8.61 
(1H, bs, 11-NH); 13C NMR (100 MHz, CDCl3) δC 16.7 (CH3, 4-C), 18.9 (CH3, 5-C), 20.8 
(CH3, 8-C), 27.7 (CH, 3-C), 32.5 (CH3, 6-C), 42.7 (CH2, 1-C), 64.9 (CH, 2-C), 124.8 (CH), 
126.6 (CH), 129.4 (CH), 137.2 (C, 12-C), 175.9 (C, 7-C), 182.2 (C, 10-C); CI MS m/z (%) 
280.3 (100, M+H), 246.3 (43), 218.3 (28), 163.1 (38), 145.2 (30); HRMS (EI) 279.1405 
(C14H21ON3S requires 279.1404). 
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(S)-(-)-N-Methyl-N-formyl valinol (S)-(-)-78: N-Methyl valinol (1.64 g, 13.9 mmol) 
was dissolved in ethyl formate (10 mL) and allowed to reflux for 16h.  The solvent 
was then removed in vacuo to afford N-Methyl-N-formyl valinol as a yellow oil 
(99%), which was carried on without purification: [α]D -16.80 (c = 1.0, CHCl3); 
1
H 
NMR (400MHz, CDCl3) δH 0.88 (3H, d, J3-H,4-H = 6.4 Hz, 4-H), 1.00 (3H, d, J3-H,5-H = 6.4 
Hz, 5-H), 1.83 – 1.87 (1H, m, 3-H), 2.79 (3H, s, 7-H), 3.02 – 3.07 (1H, m, 2-H), 3.78 – 
3.82 (2H, m, 1-H), 8.03 (1H, s, 6-H). 
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(S)-N-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-N-methyl-
formamide (S)-79:   
Method A: To a dry round bottomed flask were added phthalimide (3.07 g, 41.7 
mmol), THF (25 mL), triphenylphosphine (10.94 g, 20.85 mmol) and N-Methyl-N-
formyl valinol (3.81 g, 13.9 mmol) in that order.  The mixture was cooled to 0oC and 
diethylazodicarboxylate (6.05 g, 34.75 mmol) added.  The reaction mixture was 
warmed to rt and allowed to stir overnight.  The reaction mixture could not be 
purified. 
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Method B: [1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-methyl-
carbamic acid tert-butyl ester (2.16 g, 6.26 mmol) was dissolved in a mixture of 
CH2Cl2-TFA (2:1, 10 mL) and stirred at room temperature for 1h.  The solvent was 
then removed in vacuo and the residue dissolved in CH2Cl2 (20 mL) and washed 
with sat. NaHCO3 (2 x 10 mL).  The organic phase was dried over MgSO4 and 
concentrated in vacuo.  The resulting solid was then dissolved in formic acid (10 mL) 
and acetic anhydride (5 mL, 50 mmol) added.  The reaction mixture was allowed to 
stir at room temperature overnight.  The solvent was then removed in vacuo and 
the residue purified on a column of silica gel with a Pet Ether-EtOAc mixture (2:1) to 
afford N-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-N-methyl-
formamide (S)-79 as a white solid (1.03 g, 60%): 1H NMR (400MHz, CDCl3) δH 0.94 
(d, J = 6.8 Hz, 3H), 1.19 (d, J = 6.4 Hz, 3H) 1.97 (m, 1H), 2.71, 2.93 (2 x s, 2 x 3H), 3.54 
(dt, J = 3.6 and 10.8 Hz, 1H), 3.7 – 3.9 (m, 2H), 7.58 – 7.82 (m, 5H). 
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(S)-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-methyl-
carbamic acid tert-butyl ester (S)-80: To a dry round bottomed flask was added 
phthalimide (2.04 g, 13.88 mmol), THF (25 mL), triphenylphosphine (7.28 g, 27.75 
mmol) and N-methyl-N-tert-butoxycarbonyl valinol (2.0 g, 9.25 mmol) in that order.  
The mixture was cooled to 0oC and diethylazodicarboxylate (4.02 g, 23.12 mmol) 
added.  The reaction mixture was warmed to rt and allowed to stir overnight.  The 
solvent was then removed in vacuo and the residue purified on a column of silica 
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gel with a Pet Ether-EtOAc mixture (5:1).  After column chromatography the 
product was not pure however further attempts at purification were not successful.  
1
H NMR (400 MHz, CDCl3) δH 0.78 – 1.19 (15H, m, 4-H, 5-H, 9-H), 1.72 (1H, bs, 3-H), 
2.55 (3H, s, 6-H), 3.61 – 3.72 (2H, m, 1-H), 3.95 (1H, m, 2-H), 7.52 – 7.61 (2H, m, 13-
H), 7.70 – 7.80 (2H, m, 12-H). 
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(S)-N-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-N-methyl-
formamide (S)-81:  (S)-80 (2.16 g, 6.26 mmol) was dissolved in a mixture of CH2Cl2-
TFA (2:1, 10 mL) and stirred at room temperature for 1h.  The solvent was then 
removed in vacuo and the residue dissolved in CH2Cl2 (20 mL) and washed with sat. 
NaHCO3 (2 x 10 mL).  The organic phase was dried over MgSO4 and concentrated in 
vacuo.  The resulting solid was then dissolved in formic acid (10 mL) and acetic 
anhydride (5 mL, 50 mmol) added.  The reaction mixture was allowed to stir at 
room temperature overnight.  The solvent was then removed in vacuo and the 
residue purified on a column of silica gel with a Pet Ether-EtOAc mixture (2:1) to 
afford N-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]-N-methyl-
formamide (S)-81 as a white solid (1.03 g, 60%): 1H NMR (400MHz, CDCl3) δ 0.94 
(3H, d, J = 6.8 Hz, 4-H), 1.19 (3H, d, J = 6.4 Hz, 5-H) 1.95 – 1.98 (1H, m, 3-H), 2.71, 
2.93 (2 x 3H, 2 x s, 6-H), 3.54 (1H, dt, J = 3.6 and 10.8 Hz, 2-H), 3.7 – 3.9 (2H, m, 1-H), 
7.58 – 7.82 (4H, m, 10-H, 11-H). 
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(S)-N-(1-Aminomethyl-2-methyl-propyl)-N-methyl-formamide (S)-82: (S)-81 (516 
mg, 1.88 mmol) was dissolved in EtOH and hydrazine hydrate (302 mg, 9.45 mmol) 
added.  The reaction mixture was allowed to stir at room temperature overnight.  
The mixture was then filtered and the precipitate washed with Et2O.  The solvent 
was removed and the crude mixture carried on without purification. 
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(S)-Valinol (S)-84: To a suspension of valine 83 (10.04 g, 85.7 mmol) in THF (100 mL) 
at 0 oC was slowly added LiAlH4 (6.7g, 0.18 mol).  The reaction was allowed to stir at 
this temperature or 2h and was then heated overnight at 70 oC.  The mixture was 
then cooled to 0 oC, NaSO4.10H2O was added to remove excess LiAlH4 and the 
mixture was then filtered through Celite.  The solvent was then removed in vacuo 
to afford (S)-valinol (5.81 g, 66%) as a pale yellow oil: 1H NMR (400MHz, CDCl3) δH 
0.98 (3H, d, J4-H,5-H = 4.1 Hz, 4-H), 1.01 (3H, d, J4-H,5-H = 6.5 Hz, 5-H), 1.59 – 1.61 (1H, 
m,), 1.86 (3H, br s,), 2.54 – 2.57 (1H, m,), 3.32 (1H, m,), 3.66 (1H, dd, J = 3.95, 10.44 
Hz,) in accordance with literature.[84] 
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(S)-(-)-N-tert-butoxycarbonyl valinol (S)-(-)-85:  To a solution of valinol (S)-84 (5.0 g, 
48.5 mmol) in CH2Cl2 (50 mL) at 0 
oC was added di-tert-butyl dicarbonate (12.7 g, 
58.15 mmol) and triethylamine (13.5 mL, 96.9 mmol) and the reaction mixture 
allowed to stir at room temperature for 16 h.  The reaction mixture was then 
acidified to pH 5 with 2 M HCl and extracted with CH2Cl2 (3 x 25 mL).  The organic 
layer was then dried over MgSO4, filtered and concentrated in vacuo to afford N-
tert-butoxycarbonyl valinol (S)-(-)-85 (8.32 g, 84%) as a yellow oil; [α]D -15.0 (c = 2.0, 
CHCl3);  
1
H NMR (400MHz, CDCl3) δH 0.84 (3H, d, J3-H,4-H = 7.6 Hz, 4-H), 0.90 (3H, d, J3-
H,5-H = 7.1 Hz, 5-H), 1.38 (9H, s, 8-H), 1.77 (1H, m, 3-H), 3.35 (1H, m, 2-H), 3.55 (1H, 
m, 1α-H), 3.63 (1H, m, 1β-H), 4.58 (1H, bs, NH); 13C NMR (100 MHz, CDCl3) δC 18.6 
(CH3, 4-H), 19.5 (CH3, 5-H), 28.4 (CH3, 8-C), 29.4 (CH, 3-C), 46.2 (CH2, 1-C), 58.1 (CH, 
2-C), 85.2 (C, 7-C), 156.9 (C, 6-C) in agreement with literature values.[85] 
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(S)-[1-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-2-methyl-propyl]carbamic acid 
tert-butyl ester (S)-86:  To a dry round bottomed flask was added phthalimide (4.51 
g, 30.68 mmol), THF (100 mL), triphenylphosphine (16.08 g, 61.3 mmol) and N-tert-
butoxycarbonyl valinol (S)-85  (4.15 g, 20.45 mmol) in that order.  The mixture was 
cooled to 0 oC and diethylazodicarboxylate (8.04 mL, 51.0 mmol) added.  The 
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reaction mixture was warmed to room temperature and allowed to stir overnight.  
The solvent was then removed in vacuo and the residue purified on a column of 
silica gel with a Petrol-EtOAc mixture (5:1).  After column chromatography (S)-86 
was isolated (48%) but was not pure and further attempts at purification were not 
successful.  1H NMR (400 MHz, CDCl3) δH 0.93 (3H, d, J3-H,4-H = 6.8, 4-H), 0.95 (3H, d, 
J3-H,5-H = 6.8, 5-H) 1.10 (9H, s, 8-H), 1.81 – 1.89 (1H, m, 3-H), 3.67 -3.74 (1H, m, 2-H), 
3.85 – 3.93 (2H, m, 1-H), 4.70 (1H, d, J = 9.8 Hz, NH), 7.67 – 7.77 (2H, m), 7.78 – 7.91 
(2H, m); MS CI m/z (%) 333.3 (M+H, 27), 277.2 (100), 233.2 (55), 172.3 (31). 
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(S)-1-amino-2-tert-butyl carbamate-3-methyl butane (S)-87: To a solution of crude 
(S)-86 in EtOH (10 mL) was added hydrazine hydrate (2.88 g, 90.0 mmol).  The 
reaction mixture was allowed to stir overnight at room temperature.  The reaction 
mixture was then filtered and washed with Et2O, the solvent was removed in vacuo 
to afford (S)-87 as an off white solid: 1H NMR (400 MHz, CDCl3) δH 0.83 (3H, d, J3-H,4-
H = 6.8 Hz, 4-H), 0.86 (3H, d, J3-H,5-H = 6.8 Hz, 5-H), 1.38 (9H, s, 8-H), 1.67 (1H, m, 3-
H), 2.54 (1H, dd, J1α-H,1β-H = 13.1 Hz, J1α-H,2-H = 7.8 Hz, 1α-H), 2.73 (1H, dd, J1α-H,1β-H = 
13.1 Hz, J1β-H,2-H = 4.0 Hz, 1β-H), 3.30 – 3.35 (1H, m, 2-H), 4.50 (1H, d, J = 10.1 Hz, 
NH); 13C NMR (100MHz, CDCl3) δC 17.5 (CH3, 4-C), 18.5 (CH3,  5-C), 28.3 (CH3, 8-C), 
30.3 (CH, 3-C), 43.8 (CH2, 1-C), 79.0 (C, 7-C), 156.5 (C, 6-C). 
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(S)-1-formylamino-2-tert-butyl carbamate-3-methyl butane (S)-88: Crude (S)-87 
was dissolved in ethyl formate (50 mL) and stirred at reflux for 24 h after which the 
solvent was removed to afford (S)-88 as an off white solid: 1H NMR (400 MHz, 
CDCl3) δH 0.88 (3H, d, J3-H,4-H = 7.6 Hz, 4-H), 0.89 (3H, d, J3-H,5-H = 7.1 Hz, 5-H), 1.37 
(9H, s, 8-H), 1.71 (1H, m, 3-H), 3.29 (2H, m, 1-H), 3.48 (1H, m, 2-H), 4.57 (1H, d, J = 
8.6 Hz, NH), 8.11 (1H, s, 9-H).  
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(S)-N-[2-[3-(3,5-Bis-trifluoromethyl-phenyl)-thioureido]-3-methyl-butyl]-
formamide (S)-90:  Reaction performed on 3.2 mmol scale utilising the same 
procedure for the preparation of (S)-65.  3,5-Bis(trifluoromethyl)phenyl 
isothiocyanate (0.5 mL, 3.3 mmol) was substituted for phenyl isothiocyanate.  (S)-
90 was purified on a column of silica gel using a Petrol – EtOAc mixture (1:2). The 
product was then recrystallised from EtOAc/Hexane but was still impure; 1H NMR 
(400 MHz, CDCl3) δH 0.96 (6H, m, 4-H, 5-H), 1.67 (1H, m, 3-H), 3.15 (1H, m), 3.34 – 
3.59 (2H, m), 4.72 (1H, bs, NH), 6.27 (1H, bs, NH), 6.61 (1H, bs, NH), 7.56 (2H, s, 9-H 
and 13-H), 8.05 (1H, s, 11-H), 8.16 (1H, s, 6-H). 
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(S)-(-)-1-(3,5-dimethylphenylcarbamoyl)-2-methylpropyldiphenyl phosphoramide 
(S)-(-)-91: (S)-tert-butyl-1-(3,5-dimethylphenylcarbamoyl)-2-
methylpropylcarbamate (S)-100 (1.21 g, 3.7 mmol) was dissolved in a TFA/DCM 
(1:2) mixture and stirred at room temperature for 1h.  To the mixture was added 
saturated NaHCO3 until pH = 7 and the resulting mixture was then extracted with 
CH2Cl2 (3 x 25 mL).  The organic layer was dried over MgSO4 and the solvent 
removed under reduced pressure.  The residue was dissolved in CH2Cl2 (25 mL) and 
diphenylphosphinic acid chloride (0.73 mL, 3.8 mmol) and triethylamine (1.03 mL, 
7.4 mmol) were added.  The mixture was allowed to stir at room temperature 
overnight after which the solvent was removed.  The residue was then dissolved in 
EtOAc (10 mL) and washed with sat. NaHCO3 solution (10 mL), 1M HCl (10 mL) and 
brine (10 mL).  The organic phase was dried over MgSO4 and the solvent removed 
under reduced pressure.  The residue was then recrystallised from ethanol to afford 
(S)-(-)-91 as an off white solid 80%; mp 184 – 187 oC [α]D = -158.4
 (c = 1.0, CHCl3);
 1
H 
NMR (400MHz, CDCl3) δH 0.80 (3H, d, J3-H,4-H = 6.4 Hz, 4-H), 0.98 (3H, d, J3-H,5-H = 6.4 
Hz, 5-H), 2.11 (1H, m, 3-H), 2.14 (6H, s, 18-H), 3.98 (2H, m, 2-H), 6.65 (1H, s, 1-NH), 
6.93 – 7.36 (8H, m), 7.47 (2H, m), 8.89 (1H, s, 2-NH); 13C NMR (100 MHz, CDCl3) δC 
17.9 (CH3, 4-C), 18.5 (CH3, 5-C), 21.4 (CH3, 18-C), 29.7 (CH, 3-C), 61.9 (CH, 2-C), 117.7 
(CH), 121.6 (CH), 121.8 (CH), 126.0 (CH), 126.4 (CH), 128.4 (C), 129.7 (CH), 129.9 
(CH), 130.1 (CH), 130.2 (CH), 137.8 (C), 138.5 (C), 147.7 (C), 170.3 (1-C); EI MS m/z 
(%)  HRMS 450.1708 (C25H27O4N2P requires 450.1708); Anal. Calcd. for C25H29N2O2P: 
C 71.87 H 7.19 N 6.45. Found C 71.61 H 6.86 N 6.43. 
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(S)-94: Reaction carried out on 3.92 mmol scale utilising the same procedure as for 
(S)-91.  (S)-94 was isolated by crystallisation form EtOH in 33% yield: mp 218 – 221 
oC; 1H NMR (400MHz, CDCl3) δH 0.80 (3H, d, J3-H,4-H = 6.4 Hz, 4-H), 0.98 (3H, d, J3-H,5-H 
= 6.4 Hz, 5-H), 2.06 (1H, m, 3-H), 2.14 (6H, s, 16-H), 4.01 (1H, m, 2-H), 6.65 (1H, s, 1-
NH), 7.13 (2H, s, Ar-H), 7.35 (4H, m, Ar-H), 7.48 (2H, m, Ar-H), 8.89 (1H, s, 2-NH); 13C 
NMR (100 MHz, CDCl3) δC 17.9 (CH3, 4-C), 18.5 (CH3, 5-C), 21.4 (CH3, 16-C), 29.7 (CH, 
3-C), 61.9 (CH, 2-C), 117.7 (CH), 121.6 (CH), 121.8 (CH), 126.0 (CH), 126.4 (CH), 
128.4 (C), 129.7 (CH), 129.9 (CH), 130.1 (CH), 130.2 (CH), 137.8 (C), 138.5 (C), 147.7 
(C), 170.3 (C, 1-C); MS EI m/z (%) 450.1 (19, M), 302.1 (100); HRMS (EI) 450.1708 
(C25H27N2O4P requires 450.1705). 
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(S)-N-(diphenylphosphine oxide)-valinol (S)-95: To a solution of valinol (1.0 g, 9.69 
mmol) in CH2Cl2 (20 mL) at 0 
oC was added triethylamine (3.23 mL, 23.2 mmol) and 
diphenylphosphinic acid chloride (2.22 mL, 11.69 mmol).  The mixture was then 
allowed to reach room temperature and stirred for 16 h.  The reaction mixture was 
then diluted with 1M HCl until neutral and extracted with CH2Cl2 (3 x 25 mL).  The 
organic layer was dried over MgSO4, filtered and the solvent removed under 
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reduced pressure.  The residue was purified on a column of silica gel with a Pet 
Ether-EtOAc mixture (4:1) and then recrystallised from hexane/ethyl acetate to 
afford  a white solid (67%) which was identified as a mixture of cis/trans isomers of 
(S)-95; mp 84 – 86 oC and 95 – 101 oC; 1H NMR (400MHz, CDCl3) δH 0.62 (d, J = 6.8 
Hz, 4-H), 0.81 (d, J = 6.8 Hz, 5-H), 0.87 (d, J = 6.8 Hz, 4-H), 0.95 (d, J = 6.8 Hz, 5-H), 
1.45 (m, ), 1.91 (m, ), 2.40 (m, ), 2.99 (m, ), 7.42 (6H, m), 7.87 (4H, m).  
 
 
O
O
P
O
N
H Ph
 
 
(R,S)-(+)-1,1’-Binaphthyl-2,2’diyl-N-(α-(S)-methylbenzyl) phosphoramidate (R,S)-
(+)-96: Prepared by modification of the protocol developed by Hu[86].  The crude 
phosphoric acid chloride 101 was dissolved in CH2Cl2 (10 mL) and cooled in a salt-ice 
bath.  A solution of (S)-methylbenzylamine (1.4 mL, 10.5 mmol) and triethylamine 
(1.67 mL, 12.08 mmol) in CH2Cl2 (10 mL) was added.  The mixture was left to stir for 
30 minutes then allowed to reach room temperature and left to stir for 36 hours.  
The solution was then washed with 0.5M HCl (20 mL) and brine (25 mL), dried over 
MgSO4 and the solvent removed under reduced pressure.  The crude mixture (70%) 
of diastereomers was dissolved in refluxing ethanol (50 mL) and left to recrystallise 
over 48 hours to afford (R,S)-(+)-96 as yellow crystals; [α]D = +316
o; 1H NMR 
(400MHz, CDCl3) δH 1.48 (3H, d, J = 6.8 Hz, ), 3.31 (1H, t, J = 10.4 Hz, NH), 4.42 (1H, 
m, ), 6.69 – 7.50 (12H, m), 7.53 (1H, d, J = 4.8 Hz), 7.77 (1H, d, J = 9.2 Hz), 7.85 (2H, 
dd, J = 2.8 Hz, J = 8.4 Hz), 7.93 (1H, d, J = 8.8 Hz); 31P NMR (160 MHz, CDCl3) δP 12.30 
in agreement with the literature.[86] 
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(S)-(-)-tert-butyl-1-(3,5-dimethylphenylcarbamoyl)-2-methylpropylcarbamate      
(S)-(-)-100: Methyl chloroformate (0.55 mL, 7.15 mmol) was added dropwise to a 
stirred solution of (S)-70 (1.40 g, 6.05 mmol) and triethylamine (1.0 mL, 7.15 mmol) 
in anhydrous THF (30 mL) at 0 oC under an argon atmosphere and the mixture was 
stirred at that temperature for 2 h.  The precipitate was removed by suction 
filtration and the filtrate was added dropwise to a solution of the corresponding 
amine (8.5 mmol) and triethylamine (1.0 mL, 7.15 mmol) in anhydrous THF (30 mL) 
at 0 oC.  The mixture was allowed to stir at room temperature overnight under an 
argon atmosphere and the solvent was then removed under reduced pressure.  The 
residue was purified using column chromatography on silica gel with a petroleum 
ether-ethyl acetate mixture (4:1) to afford (S)-tert-butyl-1-(3,5-
dimethylphenylcarbamoyl)-2-methylpropylcarbamate (S)-(-)-100 as a white solid; 
mp 137 – 140 oC; [α]D -12.0 (c = 0.5, CHCl3); 
1
H NMR (400MHz, CDCl3) δH 0.75 (6H, d, 
J = 6.8 Hz, 4-H, 5-H), 1.37 (9H, s, 8-H), 2.20 (6H, s, 15-H), 2.24 (1H, m, 3-H), 4.04 (2H, 
m, 2-H), 5.36 (1H, d, J = 8.4 Hz, 2-NH), 6.59 (1H, s, 12-H), 7.18 (2H, s, 10-H, 14-H), 
8.46 (1H, bs, 1-NH); 13C NMR (100 MHz, CDCl3) δC 17.6 (CH3, 4-C), 18.3 (CH3, 5-C), 
20.2 (CH3, 13-C), 27.3 (CH3, 8-C), 30.2 (CH, 3-C), 59.9 (CH, 2-C), 78.9 (C, 7-C), 116.7 
(CH, 10-C), 124.7 (CH, 12-C), 136.6 (C, 9-C), 137.3 (C, 11-C), 155.5 (C, 6-C), 169.9 (C, 
1-C); MS EI m/z (%) 320.1 (100, M), 121.1 (100), 72.1 (88), 57.1 (73); HRMS (EI) 
320.2100 (C18H28N2O3 requires 320.2099); Anal. Calcd. for C18H28N2O3: C 66.79 H 
7.56 N 10.16. Found C 66.49 H 8.78 N 9.03. 
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Biphenyl-2,2’-chlorophosphate 101:    2,2’-biphenol (2,00 g, 10.7 mmol) was 
dissolved in toluene (25 mL) and cooled to 0 oC.  To the reaction mixture, a solution 
of POCl3 (2.40 mL, 16.0 mmol) and Et3N (4.5 mL, 32.0 mmol) was added slowly.  The 
reaction mixture was then allowed to warm to room temperature and stirred for 36 
h after which the solid residue was removed via vacuum filtration and the solution 
concentrated in vacuo to afford 101 as a yellow oil 95%: 1H NMR (400MHz, CDCl3) 
δH 
13
C NMR (100 MHz, CDCl3) δC 120.7 (CH), 126.7 (CH), 127.3 (6-C), 129.4 (CH), 129.7 
(CH), 146.7 (1-C); 31P NMR (160 MHz, CDCl3) δP 10.17; EI MS m/z (%) 266.0 (100, M), 
168.1 (76), 139.1 (24), 82.9 (48); HRMS (EI) 265.9900 (C12H8O3ClP requires 
265.9902) in agreement with literature.[87] 
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Phosphoric acid chloride 102: Prepared following the protocol developed by Hu[86].  
Racemic Binol (3 g, 10.5 mmol) was slurried in CH2Cl2 (100 mL) and POCl3 (2.25 g, 
14.7 mmol) was added followed by slow addition with stirring of triethylamine (2.6 
g, 25.5 mmol) so as to maintain gentle reflux.  After 1h the reaction mixture was 
washed with water (25 mL) and evaporated to afford the crude acid chloride 102 
which was carried on without purification. 
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(R),(R)-105: Diamine (-)-104 (50 mg, 0.24 mmol) was dissolved in CH2Cl2 (2 mL) and 
diphenylphosphinic acid chloride (110 mg, 0.50 mmol) and triethylamine (0.14 mL, 
0.60 mmol) were added.  The mixture was allowed to stir at room temperature 
overnight after which the solvent was removed.  The residue was then dissolved in 
EtOAc (10 mL) and washed with sat. NaHCO3 solution (10 mL), 1M HCl (10 mL) and 
brine (10 mL).  The organic phase was dried over MgSO4 and the solvent removed 
under reduced pressure.  The residue was then recrystallised from toluene to afford 
(R),(R)-105 as an off white solid (72%): 1H NMR (400MHz, CDCl3) δH 4.19 (2H, m, 1-
H), 5.81 (2H, m, NH), 6.77 (4H, m, Ar-H), 7.04 (6H, m, Ar-H), 7.15 (6H, m, Ar-H), 7.32 
(8H, m, Ar-H), 7.43 (2H, m, Ar-H), 7.58 (4H, m, Ar-H), 7.71 (4H, m, Ar-H); 13C NMR 
(100 MHz, CDCl3) δC 61.7 (CH), 126.9 (CH), 127.4 (CH), 128.0 (CH), 128.1 (CH), 128.3 
(CH), 128.4 (CH), 128.5 (CH), 131.0 (C), 131.5 (CH), 131.6 (CH), 131.6 (CH), 131.8 (C), 
131.9 (C), 131.9 (CH), 133.0 (CH), 141.9 (C), 142.0 (C); MS FAB m/z (%) 613.1 (77, 
M+H), 396.1 (48), 306.1 (86), 201.5 (100), 107.7 (41); HRMS (FAB) 613.2174 
(C38H35N2O2P2 requires 613.2179). 
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(S)-(-)-N-Formyl-valinol: Valinol (4.64 g, 44.9 mmol) was dissolved in ethyl formate 
(20 mL) and allowed to reflux for 16h.  The solvent was removed in vacuo to afford 
N-Formyl-valinol as a yellow oil which was carried on without purification; [α]D -
32.9 (c = 1.0, CHCl3); 
1
H NMR (400MHz, CDCl3) δH 0.90 (3H, d, J4-H,3-H = 6.8 Hz, 4-H), 
0.98 (3H, d, J5-H,3-H = 6.8 Hz, 5-H), 1.85 (1H, m, 3-H) 2.29 (1H, m, 2-H), 3.34 (1H, dd, 
J1α-H,1β-H, J1α-H,2-H = 10.4 Hz, 1α-H), 3.64 (1H, dd, J1α-H,1β-H = 6.4 Hz, J1β-H,2-H = 4.0 Hz, 1β-
H), 8.19 (1H, s, 6-H); 13C NMR (100 MHz, CDCl3) δC 18.6 (CH, 4-C), 19.3 (CH, 5-C), 
29.3 (CH, 3-C), 55.9 (CH, 2-C), 63.3 (CH2, 1-C), 165.7 (C, 6-C); CI MS m/z (%) 132.2 
(100, M+H), 114.2 (45), 104.2 (22); HRMS (CI) 132.1025 (C6H14NO2 requires 
132.1022); Anal. Calcd. for C7H15NO2: C 57.90 H 10.41N 9.65. Found: C 57.87 H 
10.36 N 9.47 in agreement with literature values.[88] 
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(S)-(-)-2-(5-Phenyl-4,5-dihydro-thiazol-2-yl)-pyridine (S)-(-)-119:  To a solution of 
(S)-130 (1.29 g, 4.99 mmol) in THF (15 mL) at 0oC was added mesyl chloride (0.57 
mL, 7.01 mmol) and triethylamine (2.15 mL, 14.3 mmol).  The reaction was then 
allowed to stir at room temperature for 48h.  Water (10 mL) was then added and 
the mixture extracted with DCM (3 x 20 mL).  The organic layer was dried over 
MgSO4 and the solvent removed in vacuo.  The crude solid was then purified on a 
column of silica gel (20 g) with a Pet Ether-EtOAc mixture (1:1) to afford an off 
white solid which was recrystallised from EtOH to afford 2-(5-Phenyl-4,5-dihydro-
thiazol-2-yl)-pyridine (S)-(-)-119 as a white crystalline solid (0.98 g, 82%); mp 105 – 
106 oC; [α]D –77.50 (c 1.0, CHCl3);
 1
H NMR (400 MHz, CDCl3) δH 4.60 (1H, dd, J8α-H,8β-H 
= 16.4 Hz, J9-H,8α-H = 5.8 Hz, 8α-H), 4.82 (1H, dd, J8α-H,8β-H = 16.4 Hz, J9-H,β-H = 9.1 Hz, 
8β-H), 4.99 (1H, dd, J9-H,8α-H = 5.8 Hz, J9-H,β-H = 9.1 Hz, 9-H), 7.17 – 7.33 (6H, m), 7.73 
(1H, dt, J = 7.8 Hz, J = 1.8 Hz), 8.05 (1H, dt, J = 7.8 Hz, J = 1.0 Hz), 8.60 (1H, ddd, J = 
4.8 Hz, J = 1.0 Hz, J = 0.8 Hz); 13C NMR (100 MHz, CDCl3) δC 53.5 (CH, 9-C), 73.9 (CH2, 
8-C), 121.6 (CH), 125.5 (CH), 127.2 (CH), 127.7 (CH), 128.9 (CH), 136.6 (CH), 142.2 
(C, 2-C), 149.4 (CH), 151.2 (C, 9-C), 170.2 (C, 7-C); MS EI+ m/z (%) 240.1 (M+, 100), 
118.0 (49), 78.0 (74), 51.0 (20); HRMS (EI) 240.0721 (C14H12N2S requires 240.0718). 
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(S)-(-)-1-(5-Phenyl-4,5-dihydro-thiazol-2-yl) isoquinoline (S)-(-)-120:  
Method A: (R)-(-)-N-(2-hydroxy-2-phenylethyl)isoquinoline-1-carboxyamide (R)-136 
(100 mg, 0.34 mmol) and Lawesson’s reagent (165 mg, 0.41 mmol) were dissolved 
in HMPA (2.0 mL) and heated at 120 oC overnight.  The reaction mixture was then 
allowed to cool down and acidified to pH = 3 with 2M HCl and the precipitate 
filtered off.  The filtrate was then extracted with CH2Cl2 (3 x 30 mL) and the organic 
layer washed with water (3 x 15 ml).  The organic layer was dried over MgSO4, 
filtered and the solvent removed.  The crude residue was then purified on a column 
of silica gel with a Petrol – EtOAc mixture (5:1) to afford (S)-(-)-120 as a brown oil (7 
mg, 7%). 
 
Method B: (R)-138 (253 mg, 0.71 mmol) and Lawesson’s reagent (344 mg, 0.85 
mmol) were dissolved in toluene (20 mL) and heated at 85 oC overnight.  The 
reaction mixture was then allowed to cool down and acidified to pH = 3 with 2M 
HCl and the precipitate filtered off.  The filtrate was then extracted with CH2Cl2 (3 x 
30 mL) and the organic layer washed with water (3 x 15 ml).  The organic layer was 
then dried over MgSO4, filtered and the solvent removed.  The crude residue was 
then purified on a column of silica gel with a Pet Ether – EtOAc mixture (5:1) to 
afford (S)-(-)-120  as a yellow oil (74%): [α]D = -22.9
o (c = 1.0, CHCl3);
 1
H NMR 
(400MHz, CDCl3) δH 4.78 (1H, dd, J = 4.3, 15.2 Hz, 2-H), 4.83 – 4.89 (1H, m, 1α-H), 
5.02 – 5.06 (1H, m, 1β-H), 7.17 (m, 1H), 7.21 – 7.25 (m, 2H), 7.33 – 7.35 (m, 2H), 
7.59 – 7.66 (m, 3H), 7.89  - 7.97 (m, 1H), 8.52 (d, J = 5.6 Hz, 1H), 9.42 (dd, J = 1.5, 7.8 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δC 52.2 (CH, C-2), 75.2 (CH2, C-1), 123.2 (CH), 
126.4 (C-3), 127.0 (CH), 127.2 (CH), 127.5 (CH), 127.6 (CH), 128.9 (CH), 130.4 (CH), 
136.9 (C-14), 141.5 (CH), 142.4 (CH), 149.2 (C-9), 168.1 (C-8), 170.9 (C-7); MS EI m/z 
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(%) 290.1 (M+, 100), 186.0 (44), 128.0 (92), 91.0 (28); HRMS EI 290.0878 (C18H14N2S 
requires 290.0879). 
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(S)-(+)-2-(5-Phenyl-4,5-dihydro-thiazol-2-yl)-quinoline (S)-(+)-122: Reaction carried 
out on a 3.66 mmol scale utilising the same procedure as for (S)-(-)-119.  After 
recrystallisation from EtOH (S)-(+)-122 was isolated as black crystals (77%); mp 118 
– 120 oC; [α]D +126.6 (CHCl3, c = 0.25); 
1
H NMR (400MHz, CDCl3) δH 4.66 (1H, dd, 
J12α-13 = 6.0 Hz, J12α-12β = 16.4 Hz, 12α-H), 4.87 (1H, dd, J12β-13 = 9.2 Hz, J12α-12β = 16.8 
Hz, 12β-H), 5.02 (1H, dd, J12α-13 = 6.0 Hz, J12β-13 = 9.2 Hz, 13-H), 7.20 (1H, m, Ar-H), 
7.25 (2H, m, Ar-H), 7.32 (2H, m, Ar-H), 7.53 (1H, m, Ar-H), 7.67 (1H, m, Ar-H), 7.78 
(1H, m, Ar-H), 8.15 (3H, m, Ar-H); 13C NMR (100 MHz, CDCl3) δC 53.4 (CH, 12-C), 74.1 
(CH2, 13-C), 118.7 (CH), 127.3 (CH), 127.6, (CH), 127.7 (CH), 127.9 (CH), 128.9 (CH), 
128.9 (C), 130.0 (CH), 130.1 (CH), 136.6 (CH), 142.3 (C), 147.6 (C), 151.1 (C), 171.0 
(C); MS CI m/z (%) 291.2 (100, M+H); HRMS (CI) 291.0956 (C18H15N2S requires 
291.0953). 
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(R)-(-)-2-Hydroxy-2-phenyl acetamide (R)-(-)-127: Prepared according to the 
protocol of Brunner[78], acetyl chloride (4.4 mL) was added to a solution of (R)-
mandelic acid (8.4 g, 54.6 mmol) in methanol (200 mL) at 0 oC.  The reaction was 
then allowed to reach room temperature and stirred overnight.  The solvent was 
then removed and the solid residue dissolved in a mixture of methanol (150 mL) 
and aqueous ammonium hydroxide (28%, 445 mL) and stored in the fridge 
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overnight.  The solvent was then removed and the solid residue recrystallised from 
toluene to give pure amide (90%) as a white solid: 1H NMR (400 MHz, CDCl3) δH 2.19 
(1H, bs, OH), 5.11 (1H, s, 2-H), 5.59 (1H, bs, NH), 6.02 (1H, bs, NH), 7.36-7.47 (5H, m, 
Ar) in agreement with the literature.[78] 
 
 
NH2HO
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(R)-(-)-2amino-1-phenyl ethanol (R)-(-)-124: Prepared according to the protocol 
developed by Brunner[78], to a suspension of (R)-(-)-2-Hydroxy-2-phenyl-acetamide 
(R)-(-)-127 (1.88 g, 12.4 mmol) in THF (100 mL) at 0 oC was slowly added LiAlH4 (1.2 
g, 31.03 mmol).  The reaction was allowed to stir at this temperature for 2 h and 
was then heated overnight at 70 oC.  The mixture was then cooled to 0 oC, 
NaSO4.10H2O was added to remove excess LiAlH4 and the mixture was then filtered 
through Celite.  The solvent was then removed in vacuo to afford (R)-(-)-2-amino-1-
phenyl ethanol as a yellow oil (84%); [α]D -26.6 (c = 0.5, CHCl3);  
1
H NMR (400 MHz, 
CDCl3) δH 1.78 (bs, 3H), 2.74 (1H, dd, J2α,2β = 12.8 Hz, J1,2α = 7.8 Hz, 2α-H), 2.93 (1H, 
dd, J2α,2β = 12.8 Hz, J1,2β  = 4.0 Hz, 2β-H), 4.56 (1H, dd, J1,2α = 7.8 Hz, J1,2β  = 4.0 Hz, 1-
H), 7.19-7.36 (m, 5H); 13C NMR (100 MHz, CDCl3) δC 49.2 (CH2, 2-C), 68.0 (CH, 1-C), 
126.0 (CH), 127.7 (CH), 128.5 (CH), 142.6 (C); MS CI m/z (%) 138.2 (100, M+H), 120.2 
(70); HRMS (CI) 138.0919 (C8H12NO requires 138.0918) in accordance with the 
literature.[78] 
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Methyl 2-pyridylthiocarboxylate 129: Prepared according to the protocol 
developed by Metzner et al.[89]  To a mixture of 2-picolylchloride hydrochloride (2.0 
g, 12.2 mmol) in DCM (5.0 mL) and H2O (5.0 mL), was added a saturated aqueous 
solution of NaHCO3 until neutralisation.  The mixture was then extracted with DCM 
and the organic layer dried over MgSO4.  The solvent was removed to afford the 
free amine.  Sulfur (1.18 mg, 34.5 mmol), DMF (6.0 mL) and triethylamine (5.0 mL, 
34.5 mmol) were added to the free amine and the mixture was allowed to stir for 
18h.  The reaction mixture was then cooled to 0 oC and methyl iodide (6.8 mL, 109 
mmol) was added dropwise.  The reaction mixture was then stirred at room 
temperature for 20 minutes after which ether was added until the mixture was 
homogeneous.  The reation mixture was then washed with brine (20 mL) and the 
red aqueous layer extrated with ether until it became yellow.  The organic layer was 
then dried over MgSO4 and the solvent removed in vacuo.  The residue was then 
purified on a column of silica gel (25 g) with a Pet Ether-EtOAc mixture (1:1) to 
afford methyl 2-pyridylthiocarboxylate as deep red crystals (1.05 g, 51%); 1H NMR 
(400 MHz, CDCl3) δH 2.68 (3H, s, 8-H), 7.41 (1H, ddd, J =  7.6 Hz, J = 4.8 Hz, J = 1.2 
Hz), 7.72 (1H, dt, J = 7.8 Hz, J = 1.8 Hz), 8.26 (1H, dt, J = 8.1 Hz, J = 1.0 Hz), 8.56 (1H, 
ddd, J = 1.0 Hz, J = 4.8 Hz, J = 1.8 Hz) in agreement with literature.[89] 
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N-((S)-2-hydroxy-2-phenylethyl)pyridine-2-carbothioamide (S)-130: Prepared by 
modification of the protocol developed by Masson[90].  To a solution of thioester 
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129 (1.05 g, 6.4 mmol) in THF was added amino alcohol (1.20 g, 8.5 mmol) and 
triethylamine (1.12 mL, 8.5 mmol).  The reaction mixture was allowed to stir at 
room temperature for 18h after which the solvent was removed in vacuo.  The 
residue was then purified on a column of silica gel (35 g) wlth a Pet Ether-EtOAc 
mixture (1:1) to afford Pyridine-2-carbothioic acid (2-hydroxy-2-phenyl-ethyl)-
amide as a colourless oil (1.289 g, 78%); 1H NMR (400 MHz, CDCl3) δH 3.82 (1H, ddd, 
J = 10.1 Hz, J = 8.8 Hz, J = 4.8 Hz, 8α-H) 4.35 (1H, ddd, J = 13.9 Hz, J = 7.1 Hz, J = 3.3 
Hz, 8β-H) 5.11 (1H, dd, J = 8.8 Hz, J = 3.3 Hz, 9-H), 7.24 – 7.42 (6H, m), 7.77 (1H, dt, J 
= 7.8 Hz, J = 1.7 Hz), 8.42 (1H, ddd, J = 4.8 Hz, J = 1.8 Hz, J = 1.0 Hz), 8.63 (1H, dt, 8.1 
Hz, J = 1.0 Hz), 10.50 (1H, bs, N-H). 
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Methyl 2-quinolinylldithiocarboxylate 132: Reaction carried out on a 4.67 mmol 
scale utilising the same procedure as for 129[89].  The residue was purified on a 
column of silica gel (25 g) with a Pet Ether-EtOAc mixture (1:1) to afford 132 as a 
deep pink solid (1.02 g, 100%); mp 98 – 101 oC; 1H NMR (400 MHz, CDCl3) δH 2.73 
(3H, s, 12-H), 7.57 (1H, ddd, J = 1.3 Hz, J = 7.1 Hz, J = 8.1 Hz), 7.72 (1H, ddd, J = 1.3 
Hz, J = 6.8 Hz, J = 8.3 Hz), 7.79 (1H, dd, J = 1.0 Hz, J = 8.3 Hz), 8.16 (2H, dd, J = 3.0 Hz, 
J = 8.6 Hz), 8.37 (1H, d, J = 8.6 Hz); 13C NMR (100 MHz, CDCl3) δC 20.2 (CH3, 12-C), 
119.5 (C, 5-C), 127.6 (CH), 128.4 (CH), 129.5 (C, 10-C), 130.4 (CH), 130.6 (CH), 136.6 
(CH), 146.3 (C, 2-C), 228.7 (C, 11-C); MS FAB m/z (%) 220.3 (M+H, 100), 172.8 (69), 
154.9 (40), 137.2 (46), 129.3 (38); HRMS (FAB) 220.0255 (C11H10NS2 requires 
220.0252). 
 
 
P a g e  | 104 
 
N
H
N
S
OH
1
2
3
4
5
6
7
8
9
10
11 12
13
14
15
16
17
15
16
 
 
(R)-Quinoline-2-carbothioic acid (2-hydroxy-2-phenyl-ethyl)-amide (R)-133: 
Reaction carried out on a 4.67 mmol scale utilising the same procedure as for 
130
[90].  133 was isolated as a yellow/orange oil (1.13 g, 78%);  1H NMR (400MHz, 
CDCl3) δH 3.91 (1H, ddd, J = 4.8 Hz, J = 8.6 Hz, J12α-H,NH = 13.6 Hz, 12α-H), 4.41 (1H, 
ddd, J = 3.5 Hz, J = 7.1 Hz, J12β-H,NH = 13.9 Hz, 12β-H), 5.18 (1H, dd, J = 3.5 Hz, J = 8.8 
Hz, 13-H), 7.27 – 7.30 (1H, m), 7.34 – 7.38 (2H, m), 7.43 – 7.48 (2H, m), 7.56 (1H, 
ddd, J = 1.3 Hz, J = 7.1 Hz, J = 8.1 Hz), 7.70 (1H, ddd, J = 1.3 Hz, J = 6.8 Hz, J = 8.3 Hz), 
7.80 (1H, d, J = 7.8 Hz), 8.02 (1H, d, J = 8.6 Hz), 8.21 (1H, d, J = 8.6 Hz), 8.77 (1H, d, J 
= 8.6 Hz), 10.70 (1H, bs, NH); 13C NMR (100 MHz, CDCl3) δC 52.9 (CH2, 12-C), 72.6 
(CH, 13-C), 121.4 (CH), 125.9 (CH), 127.7 (CH), 128.1 (CH), 128.3 (CH), 128.8 (CH), 
129.2 (C, 14-C), 129.9 (CH), 130.4 (CH), 137.0 (CH), 141.5 (C, 5-C), 145.5 (C, 10-C), 
150.2 (C, 2-C), 192.1 (C, 11-C).  
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(R)-(-)-N-(2-hydroxy-2-phenylethyl)isoquinoline-1-carboxyamide (R)-(-)-136: 
Methylchloroformate (0.68 mL, 8.79 mmol) was added dropwise to a solution of 1-
isoquinoline carboxylic acid, 135 (1.17 g, 7.33 mmol) and triethylamine (1.23 mL, 
8.79 mmol) in THF (30 mL) at 0 oC and stirred at that temperature for 1 h.  The 
precipitate was removed by filtration in vacuo and the filtrate added to a solution of 
(R)-2-amino-1-phenyl-ethanol, 124 , (1.19 g, 8.79 mmol) and triethylamine (1.23 
P a g e  | 105 
 
mL, 8.79 mmol) in THF (30 mL) at 0 oC and the mixture allowed to reach room 
temperature and stirred overnight.  The solvent was then removed and the residue 
purified on a column of silica gel with a Petrol – EtOAc mixture (1:1) to afford (R)-(-
)-136 as a white solid (89%); [α]D -78.6 (c = 0.5, CHCl3); 
1
H NMR (400 MHz, CDCl3) δH 
3.48 (1H, ddd, J1α,1β = 13.9 Hz, J1α,2 = 8.6 Hz, J1α,NH = 5.3 Hz, 1α-H), 3.85 (1H, ddd, 
J1α,1β = 13.9 Hz, J1β,NH = 7.1 Hz, , J1β,2 = 3.3 Hz, 1β-H), 5.08 (1H, dd, J1α,2 = 8.6 Hz, J1β,2 = 
3.3 Hz, 2-H), 7.15-7.26 (3H, m), 7.37 (2H, d, J = 7.1 Hz,), 7.49-7.57 (2H, m), 7.59 (d, J 
= 5.3 Hz, 2H), 7.70 (1H, d, J = 7.6 Hz,), 8.17 (1H, d, J = 5.6 Hz,), 8.67 (1H, t, J = 5.8 Hz, 
18-H), 9.30 (1H, d, J = 8.6 Hz, 12-H); 13C NMR (100 MHz, CDCl3) δC 47.9 (CH, 1-C), 
74.2 (CH2, 2-C), 124.6 (CH), 125.9 (CH), 126.9 (CH), 127.1 (C, 3-C), 127.7 (CH), 127.9 
(CH), 128.6 (CH), 128.8 (CH), 130.6 (CH), 137.4 (C, 11-C), 140.28 (CH), 141.9 (C, 16-
C), 147.9 (C, 10-C), 167.5 (C, 9-C) CI MS m/z (%) 293 ([M+H]+, 100), 275 (15), 186 (7), 
173 (5), 123 (4), 107 (5); HRMS (CI) 293.1288 (C18H17N2O2 requires 293.1290).  
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(R)-(-)-N-(2-tert-butyldimethylsilanoxy-2-phenylethyl)isoquinoline-1-
carboxyamide (R)-(-)-138:  (R)-136 (500 mg, 1.71 mmol), tert-butyldimethylsilyl 
chloride (309 mg, 2.05 mmol) and imidazole (291 mg, 4.28 mmol) were dissolved in 
DMF (5 mL) and allowed to stir at room temperature overnight.  The mixture was 
then diluted with aqueous NH4Cl and extracted with CH2Cl2.  The organic phase was 
washed with brine (3 x 25 mL) dried over MgSO4 and the solvent removed under 
reduced pressure to afford (R)-(-)-138 as a colourless oil (63%); [α]D -23.70 (c = 1.00, 
CHCl3); 
 1
H NMR (400 MHz, CDCl3) δH 0.01 (6H, s, 19-H, 20-H), 0.82 (9H, s, 22-H), 
3.36 (1H, ddd, J = 13.89 Hz, J = 8.4 Hz, J = 4.8 Hz, 1α-H), 3.90 (1H, ddd, J = 13.6 Hz, J 
= 8.0 Hz, J = 4.0 Hz, 1β-H), 4.90 (1H, dd, J = 8.4 Hz, J = 4.0 Hz, 2-H), 7.31 – 7.41 (5H, 
m), 7.65 – 7.84 (3H, m), 8.44 (1H, d, J = 5.6 Hz), 8.62 (1H, bs), 9.61 (1H, d, J = 5.2 Hz); 
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13
C NMR (100 MHz, CDCl3) δC -4.6  (CH3, C-19), -3.6 (CH3, C-20), 18.2 (C-21), 25.7 
(CH3, C-22), 47.9 (CH2, C-1), 74.0 (CH, C-2); MS EI m/z (%) 406.14 (M+, 5), 349.11 
(42), 221.1 (100), 185.1 (35), 128.0 (54), 73.0 (60); HRMS 406.2077 (C24H30O2N2Si 
requires 406.2076); Anal. Calcd. for C24H30N2O2Si: C 70.90 H 7.44 N 6.89. Found C 
70.81 H 7.44 N 6.69.  
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N-((R)-2-hydroxy-2-phenylethyl)isoquinoline-3-carboxamide (R)-140:  Reaction 
carried out on 2.89 mmol scale utilising the same procedure for (R)-136.  (R)-140 
was purified on a column of silica gel with a Petrol – EtOAc mixture (1:1) to afford 
the product as a white solid (43%); mp 104 – 105 oC; 1H NMR (400 MHz, CDCl3) δH 
3.86 (1H, t, J = 10.6 Hz, 1α-H), 4.21 (1H, dd, J1β,2 = 5.6 Hz, J1α,1β = 10.6 Hz, 1β-H), 5.05 
(1H, dd, J1β,2 = 5.6 Hz, J1α,2 = 10.4 Hz, 2-H), 7.23 – 7.38 (6H, m), 7.59 (1H, dt, J = 1.26 
Hz, J = 6.8 Hz), 7.66 (1H, dt, J = 1.3 Hz, J = 6.8 Hz), 7.84 (1H, d, J = 8.3 Hz), 7.90 (1H, 
d, J = 8.3 Hz), 8.22 (1H, s), 9.07 (1H, s); 13C NMR (100 MHz, CDCl3) δC 55.7 (CH2, 1-C), 
76.8 (CH, 2-C), 121.7 (CH), 126.4 (CH), 126.6 (CH), 127.5 (CH), 127.7 (CH), 128.5 
(CH), 128.5 (CH), 128.6 (CH), 128.9 (C), 130.9 (CH), 135.9 (C), 137.7 (C), 148.4 (C), 
150.8 (CH), 164.7 (9-C); CI+ MS m/z (%) 293.3 (M+H, 100), 275.3 (15), 107.2 (72), 
85.2 (88); HRMS (CI+) 293.1290 (C18H17N2O2 requires 293.1288). 
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N-((R)-2-tert butyldimethylsilyloxy-2-phenylethyl)isoquinoline-3-carboxamide (R)-
141: Reaction carried out on 1.26 mmol scale utilising the same procedure for (R)-
138.  (R)-141 was isolated as a colourless oil (59%); 1H NMR (400 MHz, CDCl3) δH 
0.01 (6H, s, 19-H, 20-H), 0.84 (9H, s, 22-H), 3.84 (1H, t, J = 10.6 Hz, 1α-H), 4.20 (1H, 
dd, J1α,1β = 10.8 Hz, J1β,2 = 5.3 Hz, 1β-H), 5.04 (1H, dd, J1α,2 = 10.4 Hz, J1β,2 = 5.6 Hz, 2-
H), 7.22 – 7.37 (6H, m), 7.58 (1H, dt, J = 1.26 Hz, J = 6.8 Hz), 7.65 (1H, dt, J = 1.3 Hz, J 
= 6.8 Hz), 7.83 (1H, d, J = 8.3 Hz), 7.87 (1H, d, J = 8.3 Hz), 8.20 (1H, s), 9.06 (1H, s); CI 
MS m/z (%) 423.3 (100, M+H), 155.2 (54); HRMS (CI) 423.1926 (C24H31N2OSiS 
requires 423.1923). 
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Chloromethyl-3-isoquinoline 143:  Prepared according to a literature procedure[91].  
Methyl-3-isoquinoline (250 mg, 1.75 mmol) and trichloroisocyanuric acid (162 mg, 
0.7 mmol) were refluxed in CHCl3 (10 mL) overnight, the mixture was then cooled to 
room temperature and filtered.  The filtrate was diluted with CH2Cl2 (20 mL) and 
washed with NaOH (2M, 2 x 15 mL) and brine (2 x 15 mL).  The organic phase was 
then dried over MgSO4, filtered and evaporated to afford 143 as a colourless oil 
(311 mg, 100%); 1H NMR (400 MHz, CDCl3) δH 5.01 (2H, s, 11-H), 7.65 (1H, ddd, J = 
1.3 Hz, J = 7.1 Hz, J = 8.1 Hz), 7.78 (1H, m), 7.94 (1H, m), 8.19 (1H, m), 9.11 (1H, d, J 
= 6.6 Hz) in agreement with literature values.[91] 
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Methyl-3-isoquinolinylthiocarboxylate 144: Prepared by modification of the 
protocol of Metzner et al[89]  To a solution of 143 (311 mg, 1.75 mmol) in DMF (6.0 
mL) was added sulfur (169 mg, 4.95 mmol) and triethylamine (0.69 mL, 4.95 mmol) 
were added and the mixture was allowed to stir for 18h.  The reaction mixture was 
then cooled to 0oC and methyl iodide (0.97 mL, 15.6 mmol) was added dropwise.  
The reaction mixture was then stirred at room temperature for 20 minutes after 
which ether was added until the mixture was homogeneous.  The reaction mixture 
was then washed with brine (20 mL) and the red aqueous layer extracted with ether 
until it became yellow.  The organic layer was then dried over MgSO4 and the 
solvent removed in vacuo.  The residue was then purified on a column of silica gel 
(25 g) with a Pet Ether-EtOAc mixture (1:1) to afford 144 as brown solid (50%); mp 
91-93 oC; 1H NMR (400 MHz, CDCl3) δH 2.81 (3H, s, 12-H), 7.66 (1H, ddd, J = 1.0 Hz, J 
= 7.1 Hz, J = 8.1 Hz), 7.81 (1H, ddd, J 1.3 = Hz, J = 6.8 Hz, J = 8.3 Hz), 7.98 (1H, d, J = 
8.3 Hz), 8.27 (1H, d, J = 8.6 Hz), 9.1 (1H, s); 13C NMR (100 MHz, CDCl3) δC 19.2 (CH3, 
12-C), 123.2 (CH), 126.3 (CH), 126.8 (CH), 127.7 (CH), 130.4 (C), 131.1 (CH), 133.3 
(C), 149.2 (CH), 151.1 (C), 226.9 (C, 11-C). 
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(S)-(+)-1-(5-phenyl-4,5-dihydro-1,3-oxazol-2-yl)isoquinoline (S)-(+)-148. 
Triethylamine (2.2 mL, 15.6 mmol) was added to a solution of (R)-136 (1.65 g, 5.6 
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mmol) in CH2Cl2 (65 mL). The reaction was then cooled to 0 ˚C and mesyl chloride 
(0.65 mL, 8.25 mmol) was added dropwise over 15 min. The reaction vessel was 
then allowed to attain room temperature and stirred overnight. The reaction 
mixture was washed with water (3 × 40 mL) and the organic layer was dried over 
MgSO4. Concentration in vacuo afforded a residue which was purified via column 
chromatography on silica gel (petroleum ether-ethyl acetate, 1:1) to give an oil 
which solidified on standing.  Recrystallisation from ether gave (S)-(+)-148 (1.2 g, 
78%) as a white solid: mp 78-80 °C (Et2O); [α]D +83.5 (c 0.5, CHCl3); IR (KBr) 700, 
759, 838 (aryl), 1645 (C=N), 2866, 2931 (CH/CH2), 3064 (aryl-H) cm
-1; 1H NMR (400 
MHz, CDCl3) δH 4.19 (1H, dd, J4α-H,4β-H = 15.2 Hz, J4α-H,5-H = 8.0 Hz, 4α-H), 4.64 (1H, dd, 
J4α-H,4β-H = 15.2 Hz, J4β-H,5-H = 10.4 Hz, 4β-H), 5.75 (1H, dd, J4β-H,5-H = 10.4 Hz, J4α-H,5-H = 
8.4 Hz, 5-H), 7.27 - 7.39 (m, 5H), 7.61-7.70 (m, 2H), 7.73 (1H, d, J = 5.2 Hz), 7.83 (1H, 
d, J = 7.2 Hz), 8.61 (1H, d, J = 5.6 Hz), 9.18 (1H, d, J = 8.4 Hz); 13C NMR (100MHz, 
CDCl3) δC 63.9 (CH2), 80.7 (CH), 123.5 (CH), 126.1 (CH), 127.2 (CH), 127.3 (CH), 127.4 
(C), 128.4 (CH), 128.6 (CH), 128.9 (CH), 130.5 (CH), 136.8 (C), 140.7 (C), 141.9 (CH), 
146.3 (C), 162.7 (C); EI MS m/z (%) 274 (M+•, 65), 168 (70), 128 (100), 101 (15), 82 
(35), 77 (10), 47 (5); HRMS (EI) 274.1105 (C18H14N2O requires 274.1106). 
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(±)-4-Amino-3-phenyl-1-pyridin-2-yl-butan-1-ol (±)-149:  
Method A:  SnCl2.2H2O (391 mg, 1.74 mmol) and 150 (158 mg, 0.58 mmol) were 
dissolved in anhydrous EtOH and heated to reflux overnight.  The reaction mixture 
was then allowed to reach room temperature and sat. NaHCO3 was added until pH 
= 8.  The mixture was then extracted with EtOAc (3 x 20 mL), the organic phase was 
dried over MgSO4, filtered and the solvent removed.  Only starting material was 
isolated. 
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Method B:  A solution of 150 (310 mg, 0.57 mmol) in EtOH (5 mL) was added to a 
round bottomed flask containing Pd/C (50 mg, 30%).  The flask was evacuated and 
filled with hydrogen three times.  The mixture was then stirred vigorously overnight 
at room temperature.  The reaction mixture was then filtered, the precipitate 
washed thoroughly with EtOH and the solvent removed in vacuo.  Only starting 
material was isolated. 
Method C:  To a solution of anhydrous nickel (II) chloride (91 mg, 0.7 mmol) in 
MeOH (5 mL) at 0 oC was added NaBH4 (133 mg, 3.5 mmol).  The mixture was 
allowed to stir for 15 min. after which 150 (190 mg, 0.7 mmol) and NaBH4 (266 mg, 
7.0mmol) were added.  The reaction mixture was then allowed to reach room 
temperature and allowed to stir for a further 45 min.  The mixture was then 
acidified with 2M HCl and extracted with ethyl acetate (3 x 20 mL).  The aqueous 
phase was then treated with ammonia solution and extracted with CH2Cl2 (3 x 20 
mL).  The CH2Cl2 phase was dried over MgSO4 and the solvent removed to give 149 
(98%) as a brown oil: 1H NMR (400MHz, CDCl3) δH 2.12 (m, 1H), 2.62 (m, 1H), 2.87 
(m, 3H), 4.62 (m, 1H) 7.03 – 7.26 (m, 7H), 7.54 (m, 1H), 8.43 (m, 1H). 
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(±)-4-Nitro-3-phenyl-1-pyridin-2-yl-butan-1-one (±)-150:  Diethylamine (0.26 mL, 
2.5 mmol) and 151 (100 mg, 0.5 mmol) were dissolved in anhydrous methanol (2 
mL).  Nitromethane (0.14 mL, 2.5 mmol) was added and the mixture heated at 
reflux overnight.  The mixture was then acidified with 2M HCl and extracted with 
DCM (3 x 20 mL).  The organic phase was then dried over MgSO4 and the solvent 
removed to afford 150 as a brown oil (41%): 1H NMR (400MHz, CDCl3) δH 3.60 (1H, 
dd, J4α,4β = 18.4 Hz, J3,4α = 7.1 Hz, 4α-H), 3.72 (dd, J4α,4β = 18.4 Hz, J3,4β = 7.1 Hz, 1H, 
4β-H), 4.18 (m, 1H), 4.61 (1H, dd, J2α,2β = 12.1 Hz, J2α,3 = 8.1 Hz, 2α-H), 4.71 (1H, d, 
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J2α,2β = 12.1 Hz, J2β,3 = 6.6 Hz, 2β-H), 7.22 (m, 5H), 7.41 (t, J = 6.3 Hz, 1H), 7.75 (t, J = 
7.6 Hz, 1H), 7.92 (d, J = 7.8 Hz, 1H), 8.59 (1H, d, J = 4.3 Hz, 15-H). 
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3-Phenyl-1-pyridin-2-yl-propenone 151: Adapting the method of Engberts[92] acetyl 
pyridine (2.06 g, 17.0 mmol) and benzaldehyde (1.85 g, 16.5 mmol) were mixed in 
water (100 mL) at 4 oC, 10% aqueous NaOH (10 ml) was added and the mixture 
stored in the fridge overnight.  The mixture was then shaken and filtered and the 
resulting solid recrystallised from ethanol to give 3-phenyl-1-pyridin-2-yl-
propenone 151 as yellow crystals (35%):  1H NMR (400MHz, CDCl3) δH 7.31 – 7.37 
(3H, m), 7.43 (1H, ddd, J = 7.6, 4.8, 1.3 Hz), 7.67 (2H, m), 7.81 (1H, dt, J = 7.8, 1.8 
Hz), 7.88 (1H, d, J2,3 = 16.2 Hz, 2-H), 8.13 (1H, dt, J = 1.0, 8.1 Hz), 8.24 (1H, d, J2,3 = 
16.2 Hz, 3-H), 8.64 – 8.67 (1H, m); 13C NMR (100 MHz, CDCl3) δC 120.9 (CH), 121.8 
(CH), 122.9 (CH), 126.6 (CH), 126.9 (CH), 128.4 (CH), 130.6 (CH), 135.2 (C), 136.8 
(CH), 137.1 (CH), 144.8 (CH), 148.8 (CH), 189.5 (C=O), 200.1 (C); IR (NaCl) ν 1700 
(C=0), 1620 (C=C) cm-1; MS EI  HRMS (EI+) 209.0841 (C14H11NO requires 209.0843) 
in agreement with the literature.[92] 
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Organocatalytic Reactions 
 
N
H
NHCl3Si
DIPEA, CHCl3
Catalyst 91 20 mol%
Proline 2.0 eq
OH OH
 
General procedure for the asymmetric allylation of aldimine 111 with 
allyltrichlorosilane: 
Aldimine 111 (49 mg, 0.25 mmol), proline (57 mg, 0.50 mmol), DIPEA (0.11mL, 0.63 
mmol) and catalyst (S)-91 (22 mg, 0.05 mmol) were dissolved in CH2Cl2 (2 mL).  The 
solution was allowed to stir at room temperature for 20 minutes after which 
allyltrichlorosilane (54 μL, 0.37 mmol) was added.  The reaction mixture was left to 
stir for 24 h after which saturated aqueous NaHCO3 (3 mL) was added to quench 
the reaction. The mixture was extracted with CH2Cl2 (3 × 10 mL) and the combined 
organic fractions were dried over MgSO4. Concentration in vacuo followed by 
chromatography on a column of silica gel with a Petrol – EtOAc mixture (4:1) 
afforded 112 as a slightly yellow oil; 1H NMR (400MHz, CDCl3) δH 2.44 – 2.59 (2H, 
m), 4.28 – 4.39 (1H, m), 5.05 – 5.11 (2H, m), 5.67 – 5.77 (1H, m), 6.31 (1H, dd, J = 
8.0 Hz, J = 1.6 Hz), 6.48 – 6.51 (1H, m), 6.58 – 6.64 (2H, m), 7.10 – 7.19 (2H, m), 7.24 
– 7.87 (4H, m). 
 
 
General procedure for the asymmetric reduction of ketones and ketimines: 
Trichlorosilane (86 μL, 0.84 mmol) was slowly added dropwise to a solution of 
catalyst (22 mg, 0.08 mmol) and the corresponding ketone (0.40 mmol) in CHCl3 (2 
mL) at –20 ˚C. The reaction mixture was stirred for 24 h at -20 ˚C, after which 
saturated aqueous NaHCO3 (1 mL) was added to quench the reaction. The mixture 
was extracted with CH2Cl2 (3 × 10 mL) and the combined organic fractions were 
dried over MgSO4. Concentration in vacuo followed by flash chromatography on 
silica gel (3 × 15 cm) with CH2Cl2 afforded sec-alcohol 30. 
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OH
 
 
(R)-(+)-1-Phenylethanol (R)-(+)-30: Isolated as a slightly yellow oil: [α]D +45.2 (c 
0.93, CHCl3, 64% ee)
[93], gives [α]D +49.0 (c 1.0, CHCl3, 98% ee)]; 
1
H NMR (400MHz, 
CDCl3) δH 1.52 (d, J = 6.4 Hz, 3H), 2.21 (bd, 1H), 4.92 (q, J = 6.4 Hz, 1H), 7.28-7.50 (m, 
5H); 13C NMR (100 MHz, CDCl3) δC 25.2 (CH3), 70.4 (CH), 125.4 (CH), 127.5 (CH), 
128.5 (CH), 145.9 (C); Chiral GC (Supelco β-DEXTM), carrier gas: He (flow 2 mL/min), 
injection temp: 220 ˚C; column temp: initial temp, 80 ˚C for 2 min; rate, 1.5 ˚C/min; 
final temperature 160 ˚C (tR = 23.31 min; tS = 24.21 min). 
 
 
 
 
O
HN O
1
2
3
4
5
6
7
8
9
10
11
12
13 14
15
1613 14
 
(+)-N-(1-(benzofuran-2-yl)ethyl)-4-methoxybenzenamine: 77% yield, purified on a 
column of silica gel with a Petrol – EtOAc mixture (95:5) to give a colourless oil, 
Chiral HPLC (Chiracel OJ-H) Hexane:iPrOH 80:20 0.75 mL min-1 (tmajor = 21.27 min, 
tminor = 24.56 min) showed 75% ee; [α]D +181 (c = 0.2, CHCl3); 
1
H NMR (400 MHz, 
CDCl3) δH 1.56 (3H, d, J11-H,10-H = 6.8 Hz, 11-H), 3.65 (3H, s, 16-H), 4.58 (1H, q, J11-H,10-H 
= 6.8 Hz, 10-H), 6.45 (1H, s, 3-H), 6.55 (2H, m, 14-H), 6.67 (2H, m, 13-H), 7.12 (2H, 
m), 7.40 (2H, m); EI MS m/z (%) 267 (M+, 65), 145 (100), 123 (44), 115 (42); HRMS 
(EI) 267.1259 (C17H17N2O requires 267.1261). 
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(+)-4-methoxy-N-(1-(thiophen-2-yl)ethyl)benzenamine:  77%, yield purified on a 
column of silica gel with a Petrol – EtOAc mixture (95:5) to give a yellow oil, Chiral 
HPLC (Chiracel OJ-H) Hexane:iPrOH 80:20 0.75 mL min-1 (tmajor = 24.25 min, tminor = 
26.89 min) showed 60% ee; [α]D +5.5 (c = 1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3) δH 
1.52 (3H, d, J7-H,6-H = 6.8 Hz, 7-H), 3.65 (3H, s, 12-H), 4.66 (1H, q, J7-H,6-H = 6.8 Hz, 6-H) 
6.52 (2H, m, 8-H), 6.67 (2H, m, 9-H), 6.88 (2H, m, 3-H, 4-H), 7.17 (1H, m, 5-H);  13C 
NMR (CDCl3, 100 MHz) δC 20.5 (CH3, 7-C), 50.6 (CH, 6-C), 55.7 (CH3, 12-C), 114.8 
(CH), 115.2 (CH), 122.9 (CH), 123.7 (CH), 128.7 (CH), 141.0 (C, 8-C), 150.5 (C, 2-C), 
152.5 (C, 11-C); EI MS m/z (%)  233 (M+, 39), 216 (54), 123 (37), 111 (92), 83 (100); 
HRMS (EI) 233.0874 (C13H15NOS requires 233.0873). 
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(-)-4-methoxy-N-(1-(pyridin-4-yl)ethyl)benzenamine:  70% yield, purified on a 
column of silica gel with a Petrol – EtOAc mixture (7:3) to give an off-white solid, 
Chiral HPLC (Chiracel OJ-H) Hexane:iPrOH 80:20 0.75 mL min-1 (tminor = 27.89 min, 
tmajor = 38.29 min) showed 82% ee; [α]D -19.0 (c = 1.0, CH2Cl2); 
1
H NMR (400 MHz, 
CDCl3) δH 1.43 (3H, d, J6-H,5-H = 6.8 Hz, 6-H), 3.63 (3H, s, 11-H), 4.31 (1H, q, J6-H,5-H = 
6.8 Hz, 5-H), 6.33 (2H, d, J8-H, 9-H = 3.6 Hz,  9-H), 6.61 (2H, d, J8-H, 9-H = 3.6 Hz,  8-H), 
7.22 (2H, d, J2-H, 3-H = 2.4 Hz, 3-H), 8.46 (2H, d, J2-H, 3-H = 2.8 Hz, 2-H); 
13
C NMR (CDCl3, 
100 MHz) δC 24.6 (CH3, 6-C), 53.5 (CH, 5-H), 55.7 (CH3, 11-H), 114.5 (CH), 114.8 (CH), 
121.3 (CH), 140.8 (C, 7-C), 149.9 (CH), 152.3 (C, 10-C), 154.9 (C, 4-C); CI MS m/z (%) 
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229 (M+, 100), 213 (8), 123 (15), 108 (12), 71 (15); HRMS (CI) 229.1341 (C14H17N2O 
requires 229.1342). 
 
 
 
1
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12 13
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10
11
 
 
(-)-4-methoxy-N-(1-(pyridin-2-yl)ethyl)benzenamine: purified on a column of silica 
gel with a Petrol – EtOAc mixture (7:3) to give an off-white solid, Chiral HPLC 
(Chiracel OJ-H) Hexane:iPrOH 80:20 0.75 mL min-1 (tminor = 27.89 min, tmajor = 38.29 
min) showed 79% ee; [α]D -15.0 (c = 0.1, CHCl3); 
1
H NMR (400 MHz, CDCl3) δH 1.45 
(3H, d, J8-H,7-H = 6.8 Hz, 8-H), 3.62 (3H, s, 13-H), 4.47 (1H, q, J8-H,7-H = 6.8 Hz, 7-H), 
6.45 (2H, d, J , 10-H), 6.62 (2H, d, 11-H), 7.06 (1H, dd, J = 7.2 Hz, J = 5.2 Hz, 5-H), 
7.27 (1H, d, J = 8.0 Hz, 3-H), 7.53 (1H, dt, J = 1.6 Hz, J = 7.6 Hz, 4-H), 8.50 (d, J = 4.98 
Hz, 6-H); EI MS m/z (%) 228 (M+, 100), 213 (98), 169 (37), 150 (97), 122 (90), 106 
(97); HRMS (EI) 228.1263 (C14H16N2O requires 228.1265) in agreement with 
literature values.[94]  
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N-(1-(furan-2-yl)ethyl)-4-methoxybenzenamine: 70% yield, purified on a column of 
silica gel with a Petrol – EtOAc mixture 94:6, , Chiral HPLC (Chiracel OJ-H) 
Hexane:iPrOH 80:20 0.75 mL min-1 (tminor = 41.51 min, tmajor = 49.19 min) showed 
55% ee; 1H NMR (400 MHz, CDCl3) δH 1.46 (3H, d, J7-H,6-H = 6.8 Hz, 7-H), 3.66 (3H, s, 
12-H), 4.47 (1H, q, J7-H,6-H = 6.8 Hz, 6-H), 6.06 (1H, d, J3-H, 4-H = 2.4 Hz, 3-H), 6.21 (1H, 
d, J3-H, 4-H = 2.4 Hz, 4-H), 6.52 (2H, d, J9-H, 10-H = 3.6 Hz, 9-H), 6.67 (2H, d, J9-H, 10-H = 3.6 
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Hz, 10-H), 7.24 (1H, s, 5-H); 13C NMR (CDCl3, 100 MHz) δC 20.9 (CH3, 7-C), 48.5 (CH, 
6-C), 55.7 (CH3, 12-C), 105.1 (CH, 3-C), 110.1 (CH, 4-C), 114.8 (CH, 9-C), 115.3 (CH, 
10-C), 141.0 (C, 8-C), 152.5 (C, 11-C), 157.4 (C, 2-C); EI MS m/z (%) 217 (M+, 55), 202 
(37), 123 (42), 95 (100); HRMS (EI) 217.1103 (C13H15N2O requires 217.1101) in 
agreement with literature values.[95] 
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4-methoxy-N-(1-phenylethyl)benzenamine: Isolated as a slightly yellow oil, Chiral 
HPLC (Chiracel OJ-H) Hexane:iPrOH 99:1 0.75 mL min-1 (tmajor = 13.12 min, tminor = 
14.36 min) showed 79% ee; 1H NMR (400 MHz, CDCl3) δH 0.87 (3H, t, J7-H,6-H = 7.8 Hz, 
7-H), 1.73 (2H, m, 6-H), 3.56 (3H, s, 12-H), 4.08 (1H, t, J6-H,5-H = 6.8 Hz, 5-H), 6.40 (2H, 
d, 9-H), 6.59 (2H, d, 10-H), 7.22 (5H, m, 1-H, 2-H, 3-H); 13C NMR (CDCl3, 100 MHz) δC 
10.9 (CH3, 7-C), 31.7 (CH2, 6-C), 55.8 (CH, 5-C), 60.6 (CH3, 12-C), 114.5 (CH), 114.8 
(CH), 126.6 (CH), 126.9 (CH), 128.5 (CH), 141.9 (C, 8-C), 144.2 (C, 4-C), 151.9 (C, 11-
C); EI MS m/z (%) 241 (M+, 57), 212 (100), 91 (67); HRMS (EI) 241.1467 (C16H19ON 
requires 241.1469) in agreement with literature.[96] 
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(+)-4-methoxy-N-(1-(5-(trimethylsilyl)furan-2-yl)ethyl)benzenamine: Isolated as a 
colourless oil, [α]D +13.4 (c = 1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3) δH 0.05 (9H, s, 
13-H), 1.35 (3H, d, J7-H,6-H = 6.8 Hz, 7-H), 3.55 (3H, s, 12-H), 4.38 (1H, q, J7-H,6-H = 6.8 
Hz, 6-H), 5.96 (1H, d, J3-H,4-H = 4.6 Hz, 3-H), 6.31 (1H, d, J3-H,4-H = 4.8 Hz, 4-H), 6.43 
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(2H, d, 9-H), 6.57 (2H, d, 10-H); 13C NMR (CDCl3, 100 MHz) δC 0.00 (CH3, 13-C), 22.5 
(CH3, 7-C), 50.2 (CH, 6-C), 57.3 (CH3, 12-C), 106.5 (CH, 3-C), 116.3 (CH, 4-C), 116.8 
(CH, 9-C), 121.7 (CH, 10-C), 142.9 (C, 8-C), 153.9 (C, 11-C), 160.7 (C, 2-C), 163.5 (C, 5-
C); EI MS m/z (%) 289 (M+, 20), 167 (70), 123 (15), 83 (99), 75 (30), 49 (100); HRMS 
(EI) 289.1498 (C16H23NO2Si requires 289.1495). 
 
O
OH
1
2
34
5
6
7
8 9
 
1-(2,5-dimethylfuran-3-yl)ethanol: Isolated as a colourless oil, 1H NMR (400MHz, 
CDCl3) δH 1.35 (3H, d, J = 6.3 Hz, 7-H), 2.16 (3H, s, 8-H), 2.17 (3H, s, 9-H), 4.71 (1H, q, 
J = 6.3 Hz), 5.93 (1H, s, 4-H); Chiral GC (Supelco β-DEXTM), carrier gas: He (flow 2 
mL/min), injection temp: 220 ˚C; column temp: initial temp, 80 ˚C for 7 min; rate, 
3.0 ˚C/min; final temperature 200 ˚C (t1 = 29.90 min; t2 = 30.08 min). 
 
 
O
OH
1
2
34
56
7
8
 
1-(5-methylfuran-2-yl)ethanol: 
1
H NMR (400MHz, CDCl3) δH 1.55 (3H, d, J7-H,8-H = 6.6 
Hz, 8-H), 2.31 (3H, s, 6-H), 4.85 (1H, dq, J = 1.5 Hz, J7-h,8-H = 6.6 Hz, 7-H), 5.93 (1H, dq, 
J3-H,4-H = 3.0 Hz, J = 1.0 Hz), 6.13 (1H, d, J = 3.0 Hz); Chiral GC (Supelco β-DEX
TM), 
carrier gas: He (flow 2 mL/min), injection temp: 220 ˚C; column temp: initial temp, 
80 ˚C for 5 min; rate, 2.0 ˚C/min; final temperature 200 ˚C (t1 = 12.32 min; t2 = 12.65 
min). 
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